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Cattle from the Iowa State University, Ames dairy herd were characterized for Johne' s disease using 
results from the milk ELISA (MELISA) (Dairy Lab Services; Dubuque, IA), serum ELISA (SELISA) (IDEXX 
Laboratories, Inc. , Westbrook, ME), y-IFN assay (CSL Limited Parkville Victoria Australia) and fecal culture. 
Using the results of the initial y-IFN assay and the SELISA determination, all herd members were divided into 
four groups consisting of: a negative SELISA and y-IFN, suspect y-IFN, positive y-IFN and SELISA positive 
individuals. The first three groups were enrolled in the skin testing trial and were randomly assigned within 
group to one of two treatments. This consisted of an injection of either l00µg (0.1ml) of a M. paratuberculosis 
strain 19698 cell free sonicate (19698 MpS) or 0.1 ml of0.9% saline solution as an intradermal injection. Blood 
samples were obtained on days 0, 3, 6, 9, 15, and 27 days post-injection for y-IFN assay, while skin lesion 
measurements were made on days 0, 3, 6 and 9. 
The MELISA test returned the greatest number oftest positive individuals at 12.96%, The SELISA was 
7.41 % test positive, y-IFN assay was 4.40%, and fecal culture yielded 0% positive. Further evaluation indicated 
the SELISA had a significantly lower age (37.2 vs. 50.5 and 48.3 months respectively) at positive test (P > [Tl = 
0.0192) than did MELISA or y-IFN. Due to the low number of fecal culture and y-IFN positive individuals, and 
the significantly lower age at positive test it could be suspect that the SELISA had an inordinate number of false 
positive individuals. 
MELISA and SELISA results were compared using an XYplot. No common individuals were identified 
as test positive by both tests. Analysis using kappa returned a value of -0.116 indicated a very low percentage 
of agreement between the two testing means. With the SELISA being the regulatory US standard it is not 
recommended to use the MELISA for purposes of culling decisions. 
Results of the skin testing portion of the study indicates that inoculation of animals with 19698 MpS 
significantly increased production of y-IFN in cattle declared to have positive (MpS-P) baseline y-IFN responses 
for Johne 's disease. Peak production ofy-IFN occurred at 144 hr following skin testing and was statistically 
significant P = 0.0005 as compared to day 0. Levels ofy-IFN dropped on day 9, but remained at levels that 
were significantly higher than day 0 (P = 0.0325). Levels of y-lFN again significantly increased on day 27 
when compared to day 15 (P = 0.0362), and was significantly higher than day 0 (P = 0.0004). Further research 
is warranted to determine if the addition of skin testing to the y-IFN assay could increase test sensitivity or 
durability. 
INTRODUCTION 
Mycobacterium avium subsp. paratuberculosis was first isolated by Drs. Johne and Frothingham in 
1895. 1'2 This is the causative agent of the disease that bears Dr. Johne ' s name. Johne's disease is a chronic 
mycobacterial infection of the lower small intestine and associated lymph nodes which affects many ruminants 
including cattle, sheep, goats, llama, deer and bison.1'3' 4 It is primarily a wasting disease, but is also evidenced 
by profuse, watery, untreatable diarrhea in cattle. 
Mycobacterium paratuberculosis is closely related to Mycobacterium. avium and it is suggested that the 
etiological agent of Johne's disease should be most properly classified as Mycobacterium avium subsp. 
Paratuberculosis. 5 For purposes of uniformity the causative agent will be referred to as M paratuberculosis in 
the balance of this paper. 
Webster's Second College Edition of the New World Dictionary defines the word "insidious" as, 
"operating in a slow or not easily apparent manner; more dangerous than seems evident." Johne 's disease truly 
defines this term for researchers, veterinary practitioners and producers alike. Bovine oral infection generally 
occurs during the first 6 - 12 months oflife with manifestation of the clinical disease 2 - 5 years later. 
Producers encountering Johne ' s will simply cull the affected animal and feel they have dealt with the problem. 
In reality, for every home-raised case of clinical Johne's there may be another 20 - 25 individuals in some form 
of infection present in the herd. 6 Removal of the clinical individual has done nothing to effectively deal with 
this disease if the other 20 - 25 cases are not dealt with. This is the true "insidious" nature of the disease. 
Management and reduction of the incidence of Johne' s disease is well worth the time and effort. 
Paratuberculosis is an economically devastating disease of ruminants . Recent estimates indicate the loss to 
dairy producers includes 640 million kg of milk, additional culling of 11,000 cows, and nearly 20,000 cow 
deaths (based on a total population estimate of9,458,000 dairy cows).7'8 The total amount of revenue lost is 
approximately $222 million. Another method of quantifying this on a herd basis is that the loss is 
approximately $227 per lactating female if 10% of the culls showed signs of infection withM paratuberculosis. 
The purpose of the National Animal Health Monitoring Study- United States Department of Agriculture 
(NAHMS) study was to begin to understand the potential individual and herd-prevalence rate occurring in the 
nation's dairy herds.7 The study suggested a 3.4% cow-level prevalence of Johne 's with approximately 21.6% 
of the nation's dairy herds being infected. Herds undergoing expansion, as represented by a herd size greater 
than 300, demonstrated a 40% herd prevalence rate. 
Johne's disease has been receiving much more attention in the last few years. As Dr. Franklyn Garry 
outlined, there is a greater prevalence of the disease than previously assumed.9 The economic impact has also 
been greater than previously determined. Recent litigation over the losses due to Johne 's has pushed the disease 
to the forefront. Additionally, there is some evidence that M. paratuberculosis could be a zoonotic agent 
connected to human Crohn's disease. 15• 72 
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Computer information management packages have made the management of thousands of cows in a 
single dairy operation a controllable task. Consolidation of dairy operations and the expansion of herd size have 
been fueled through the purchase of mature milking cows, as well as non-lactating youngstock. Current 
estimates suggest that a producer buying cattle on the open market has a 1: 10 chance of purchasing J ohne ' s 
disease in some form. 10 Increased levels of stress due to disease, housing, social and nutritional causes have 
served to shorten the presentation time of Johne ' s, thus pushing it into the consciousness of all dairy industry 
participants. The two factors of prevalence level and stress have made Johne 's disease a major cause ofrevenue 
loss in the expansion herd. 
Testing procedures have been criticized for their lack of sensitivity and specificity as all participants 
become frustrated with their inability to identify animals that have been recently, subclinically, or even 
clinically infected. Research has been stymied due to the inability to truly declare an animal non-infected. An 
additional burden is the slow 4-day generation time of M. paratuberculosis. Fecal and tissue culture have been 
considered the "gold" standard of isolation, but growth requirements of 12 - 16 weeks have taken a toll in 
research efforts. 11 Considerable work and study have been done in the 100 years since Drs. Johne and 
Frothingham isolated this organism, but we are no closer to a cure or even a truly effective vaccination 
program. 1'2 With the advent of new techniques in gamma-interferon detection and polymerase chain reaction 
amplification (PCR) ofmycobacterial DNA we are starting to break down some of the barriers to identification 
of the early, subclinically infected individuals. 
Gamma-Interferon Testing of Johne's Disease 
Testing for the presence of mycobacterial species first focused on detecting bovine tuberculosis caused 
by M bovis. Historically, the test of choice was the caudal skin fold test which called for the injection of a M 
bovis purified protein derivative (PPD) intradermally, followed by inspection of the injection site at 72 hr post-
injection for the presence of skin thickening or a welt. This was a means of visualizing the effects of an 
activated cell-mediated immune system. While criticized for lacking sensitivity and specificity the test was 
successful in removing large numbers of reactors from the bovine population and was a successful element of 
regulatory control programs. 
A recent development in cell-mediated immune system measurement has been a testing procedure to 
determine the amount of the cytokine gamma-interferon (y-IFN) released by sensitized T lymphocyctes. 
Gamma-interferon is produced by CD4+, CD8+, gamma/delta (y/o) receptor T-cells, and natural killer cells. 
Activation of the macrophage population through cytokine induction is responsible for the induction of tumor 
cell lysis, release ofreactive oxygen and nitrogen intermediates, expression of major histocompatibility 
complex class II antigens, and secretion of arachadonic acid metabolites. Thus, there is a direct relationship 
between y-IFN and activation of macrophages and their ability to kill intracellular pathogens. 12 
The detection methods of Johne ' s disease caused by M. paratubercu/osis have been limited to the use of 
the intradermal skin test, detection of the organism through culture, and the assay of serum for the detection of 
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antibody production. The caudal skin fold test has come under scrutiny for poorer sensitivity and specificity in 
the case of Johne 's disease due to the remote location (immunologically) of the lesions.12 Culture and antibody 
detection have been very successful in identifying clinically affected individuals, but historically poor in the 
detection of subclinical cases. It is generally accepted that the late phase reactions of Johne' s disease are to 
shed bacilli in large numbers, along with the production of non-neutralizing antibody. Conversely, the earliest 
measurable immune system response to infection of M. paratuberculosis is the activation and differentiation of 
the T cell population which is the cell-mediated phase of immunity. 12 
Due to the poor detection rate of the cell-mediated phase of disease by the intradermal Johne's test, 
research moved to adapt the y-IFN assay used in bovine tuberculosis to the detection of Johne 's disease. The 
use of this assay presents real benefits through earlier detection of Johne ' s disease, increased sensitivity and 
specificity over caudal fold skin testing and other means of testing, automated, numerical determination of y-
IFN levels vs. the subjective intradermal palpation technique, as well as the ability to run the test multiple times 
without sensitization of the animal to an intradermal PPD. While the benefits are great, this form of testing 
does have the drawbacks oftest expense ($16/animal) and the requirement that a heparinized whole blood 
sample be delivered to the laboratory within 16 hours after drawing. The latter factor can represent a great 
logistical hurdle for veterinary practitioners in the field. 
Focus of this Study 
Recent work using the y-IFN assay for the detection of bovine tuberculosis has examined the effects of 
the intradermal injection of a PPD in an effort to "magnify" the y-IFN production of already stimulated T 
lymphocytes. Whipple et al. demonstrated a stimulatory production (p<0.01) of y-lFN in response to the 
administration of a M. bovis PPD intradermal injection used in a caudal fold skin test. 13 Optical density values 
of the y-IFN ELISA for samples taken 72 hr post-inoculation were significantly higher than samples collected 
prior to skin testing, and higher than samples from cattle that were not skin tested. Likewise, Rothel et al. 
demonstrated a 2.5 fold increase in y-IFN following caudal fold testing that peaked at 3 - 5 weeks post-
inoculation. 14 
The y-IFN assay has demonstrated real benefits in terms of improved sensitivity, specificity and 
standardization oftechnique.63'65 The demonstrated "magnification" effect in y-IFN production could 
potentially further enhance the sensitivity of the y-IFN assay in determining positive reactors to Johne's disease 
without loss of specificity. An additional benefit could be increased longevity of the heparinized blood sample. 
It is possible that even though lymphocyte survival may be compromised, enough lymphocytes may still be 
present at an enhanced y-IFN production level to make the test effective. Given the stimulatory phenomenon 
documented with M. bovis, this study was undertaken to determine if the same stimulatory activity occurred in 
M. paratuberculosis y-IFN assay reactors. 
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Thesis Organization 
This thesis begins with a literature search examining the aspects of Johne ' s disease in bovines which 
includes: Economics and Milk Production, Transmission of M. paratuberculosis, Clinical and Gross Pathology, 
Immunology of Jor,ne ' s Disease, Immunology and Transmission, Vaccination against Johne 's Disease, Testing 
Procedures, Organism Detection, Treatment of Johne ' s Disease, Regulatory Concerns, Crohn' s Disease, 
followed by a Literature Review Conclusions. 
Experimental work for this thesis produced two journal articles to be submitted to the American Journal 
of Veterinary Research. The first article (Chapter 3) is: Comparisons of the Milk ELISA, Serum ELISA, 
Gamma-Interferon and Fecal Culture Tests for the Detection of Johne ' s Disease in an Iowa (United States) 
Dairy Herd. This study served as the initial classification trial to enroll individual animals in the second phase 
of the experiment. The second article (Chapter 4) is: Effect of a Skin test using a Cell-free Sonicate of 
Mycobacterium avium subsp. paratuberculosis (19698) on the Production of Gamma-Interferon. Enrolling 
cattle in this phase of the study required the testing procedures that were outlined in the Materials and Methods 
section of the first article. The reader is directed to the first article for the complete Materials and Methods. 
Only the procedures that were utilized in the second phase of experimentation are outlined in the Materials and 
Methods of the second article. 
The references for both journal articles are included with the references of the literature search at the end 
of the thesis. A general conclusions chapter follows the journal articles. 
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LITERATURE REVIEW 
Paratuberculosis (Johne's disease) is a chronic, granulomatous inflammation that affects the caudal 
region of the small intestine, the ileocecal valve, the cecum, and the associated lymph nodes.3 Johne's disease 
is widely distributed internationally in domesticated ruminants such as cattle, sheep, goats, deer, antelope, and 
bison.4 Cattle become infected as calves through oral ingestion of the bacilli or through in-utero infection. Due 
to the slow growing nature of this pathogen disease doesn't become clinically evident until 2 to 5 years of age.4 
Johne's disease is manifested by weight loss, diarrhea that lasts more than three days, and the failure to 
respond to therapy. Affected cattle do not have a fever, tend to eat well, and look well other than the presence 
of diarrhea and weight loss. 15 Internal tissue changes associated with this disease result in the leakage of plasma 
proteins across the intestinal wall, and the malabsorption of dietary amino acids from the intestinal contents 11 . 
These changes are the cause of the clinical diarrhea. With the loss of dietary amino acids the affected animal 
may potentially manifest a "bottle jaw" appearance (mandibular edema). 16 Differential diagnoses include renal 
amyloidosis, abdominal neoplasia, caudal vena cava thrombosis, heart failure, indigestion, salmonellosis, 
parasitism, internal abscess, or other disease entities that may cause chronic diarrhea. 17• 18 
Mycobacterium paratuberculosis is a gram-positive, intracellular, slow-growing, mycobactin-dependent 
acid-fast bacterium, closely related to Mycobacterium avium. 19 There are some phenotypic and genotypic 
differences between M. avium subsp paratuberculosis and the M. avium complex, but much more similarity 
exists than differences.5 This is evidenced by 98% of the genome of M. avium being conserved in the genome 
of M avium subsp. Paratuberculosis. 20 This conservancy represents a real diagnostic challenge due to cross-
reactivity. 
M. paratuberculosis lacks the ability to produce mycobactin, which is a siderophore produced by all 
other mycobacteria. Mycobactin assists in making iron available from the environment for bacillary growth, 
and must be supplied in the growth media for M. paratuberculosis isolation. Because of this siderophore 
deletion M. para tuberculosis is considered to be a parasite of the mammalian cell. As no recovery from 
infection is known, this organism should be considered to be an obligate parasite.21 
The National Animal Health Monitoring Study- United States Department of Agriculture (NAHMS) 
study was initiated in 1995 to begin to understand the potential individual and herd prevalence rates occurring 
in the nation's dairy herds.7 Using a conservative protocol, all herds that had only 1 positive serological 
isolation from the statistical sample were excluded from the study. Greater than 1 isolation allowed herd 
inclusion. The best estimate indicated a 21.6% herd prevalence rate, which excluded the 0.6% of dairy herds 
currently vaccinating for this disease. The adjusted cow-level prevalence was 3.4%. Other studies indicate cow-
level prevalence rates at approximately 5% to 10%. 22• 23 Collins et al indicated that 34% of Wisconsin herds 
surveyed had serological evidence of Johne's with a 4.79% incidence rate among cows 15•23 . Of the 79 herds 
with seropositive cattle, 31.6% had > 15% of the herd population test positive for paratuberculosis. Work by 
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Johnson-Ifearulundu and Kaneene indicated a 66% prevalence rate in Michigan dairy cattle.24 Thorne and 
Hardin suggested that 74% of Missouri dairy herds and 40% of beef herds are infected.25 These high herd 
prevalence rates indicate a serious threat 23 . With these statistics in mind it is generally accepted that a producer 
has a 10% chance of purchasing an animal with J ohne' s disease from market sources. Any producer purchasing 
cattle on the open market thus will be ensured of having a baseline level of Johne's disease. As most 
acquisition is in association with expansion efforts, this increased risk was demonstrated by the NAHMS study, 
which indicated approximately 40% of the herds over 300 mature cattle were infected. 10 It is assumed that to 
achieve herd sizes of 300, some animal purchasing from the open market was required. 
An absorbed ELISA for detection of antibodies against Mycobacterium paratuberculosis was performed 
on serum samples obtained from the Missouri Animal Health Laboratory.25 Samples from 1954 Missouri cattle 
representing 89 herds were randomly selected from samples submitted for Brucellosis testing. The apparent 
seroprevalence ofparatuberculosis in dairy cattle (8 ± 3%) was similar to that in beef cattle (5 ± 2%). When 
herds were classified as dairy or beef, 74% (14 of 19) of dairy herds and 40% (27 of 68) of beef herds were 
positive. 
As a part of the NAHMS study, participating producers were surveyed concerning their familiarity with 
the disease, 17.7% considered themselves to be fairly knowledgeable, 37.1 % knew some basics, 35.3% 
recognized the name, while 9 .9% had never heard of it before. 7 This indicates that a fairly sizable educational 
effort will be needed prior to the implementation of any control efforts. 
Economics and Milk Production 
Johne's disease is economically devastating. In herds that are heavily infected there is no doubt in the 
owner's mind based on the perceived loss of milk production and loss of body condition at culling. These are 
easy parameters to see, but additional losses accrue through reductions in fertility, loss of genetic material and 
through the reduction of future earnings through early culling. A further loss is through higher susceptibility to 
concurrent disease from immune system compromise due to the lack of absorbed nutrients. Benedictus 
partitioned these losses as follows: increased veterinary costs (2%), loss due to idle production facilities (3%), 
decreased value at slaughter (20%), decreased production (32%), and unrealized future income based on age at 
culling and prior production ( 4 3 % ) . 26 
Production losses have been demonstrated in several studies. Benedictus et al found a 16% reduction in 
milk yield of the final lactation of cows with clinically evident para tuberculosis. The production losses of 
infected animals without clinical signs were about 6%.26• 27 This study also showed that infected high producers 
(productive potential 8% to 9% greater than herdmates) within a herd are more likely to develop clinical signs. 
Thus these animals have a higher risk of being culled. A study performed in 3 northern California dairy herds 
supported the above results by indicating 1838 lb (15%) less milk on a 305 day mature equivalent basis in 
subclinically infected animals.28 A Netherlands study showed reduced production in culture positive cows by 
12 lb per head per day. Clinical individuals demonstrated a 19.5% reduction on a mature equivalent basis.29 
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When examining lactation records, a New York cull cow study demonstrated the progression of milk 
yield losses. When compared to 2 lactations prior to culling, the lactation record the year prior to culling 
returned a 6% milk yield decrease. The lactation record of the year of culling was depressed by 16% when 
compared with the reference lactation, 2 lactations previous. The Netherlands study previously mentioned 
demonstrated a similar 5% decrease in milk production in the cull lactation vs. the lactation previous. Most 
studies indicate a greater than 15% milk yield loss for clinically infected individuals when compared to their 
own records, or uninfected herdmate records. Subclinical cows experienced a moderate reduction of 5% to 
15%.30 A New York examination of a 210 cow Holstein herd found no changes in milk yield of infected heifers 
as compared to non-infected herdmates.31 Beginning in the second lactation, and increasing with advancing 
parity, milk yield losses increased. Using a pay price of $13 .00/hundredweight of milk the authors determined 
milk yield losses of $80.00 to $250.00 per lactation per individual. 
Returning to the NAHMS Dairy 96 study, Johne's disease is estimated to cost US dairy producers almost 
640 million kg of milk, additional culling of 11,000 cows, and nearly 20,000 cow deaths annually (based on a 
1995 estimate of9,458,000 dairy cows).7 In addition, of the estimated $60 million in lost revenue for culls in 
poor body condition, $9 million can be attributed to Johne ' s disease. Thus, the total amount of annual revenue 
loss from Johne's disease is approximately $222 million.8 Realizing that Johne's is a bovine problem and not 
just a dairy issue, the National Cattlemen's Beef Association (NCBA) moved to incorporate producer education 
about Johne's disease into their Beef Quality Assurance program in 1998. It is critical to control efforts that 
Johne ' s disease be viewed as bovine problem rather than a dairy issue. Participation by the beef industry will 
be essential to implement control programs.9 
When examining health related parameters such as mastitis incidence or infertility the overall conclusion 
of studies are less clear. Several studies did not indicate a correlation between Johne' s and these events, while 
others did find a correlation. Given the lack of dietary nutrients in the advanced stage of this disease it could be 
assumed that there would be a logical association due to irnmunosuppression. A major challenge in studying 
these parameters is the difficulty in determining the true infective status of individuals in the early course of 
disease.30 
A study by Elsken and Nonnecke attempted to provide information on this area.32 Blood lymphocytes 
were obtained from control, subclinically infected and noninfected cows. Lymphocytes obtained from 
peripheral blood samples of infected cows demonstrated significant proliferation (P < 0.05) while milk 
lymphocytes did not. Conversely, milk lymphocytes from noninfected cows demonstrated significant 
proliferation (P < 0.05) while their vascular pool lymphocytes did not. Epidemiological work suggests that 
cows with subclinical paratuberculosis are more susceptible to mastitis and are culled for chronic mastitis more 
frequently than are noninfected herdmates. Possibly, cows infected with M. paratuberculosis may be more 
susceptible to mammary gland infections, or there could be an early, selective depression of mammary gland 
protective mechanisms.32 Conversely, a study by Wilson et al. examining a 210 cow Holstein herd divided into 
an infected and non-infected herd demonstrated significantly lower rates of new and chronic mastitis infections 
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(P < 0.05, P = 0.05, respectively) in the infected herd.31 Their work did verify lower mature equivalent herd 
production and increased culling among the members of the Johne' s infected herd. 
In addition to milk production one of the biggest losses sustained by the dairy industry is the premature, 
or involuntary, culling of affected cattle. Voluntary culling is the removal of individuals from the herd based on 
production reasons or for sale to another dairy for dairy purposes. Voluntary culling allows the dairy producer 
to improve the herd through removal of low genetic merit cows. A herd experiencing a high rate of clinical 
Johne ' s disease will have the culling program taken over by involuntary removal relating to paratuberculosis. 
The loss of high merit genetic individuals is an opportunity cost and is extremely difficult to quantify.30 
Additionally, losses continue to accrue through increased replacement animal costs due to the accelerated 
culling rate. 
Transmission of M. paratuberculosis 
Attempting to understand control of this disease requires that the veterinary practitioner and producer be 
well acquainted with the modes of contamination and transmission. This section will focus on the events of 
transmission starting at the in-utero stage and moving through the life of the bovine. 
M. paratuberculosis is an inhabitant of the infected animal ' s gastrointestinal tract (GI tract) and the 
associated mesenteric lymph nodes. This organism is intracellular in nature and lives within macrophages in 
the lamina propria of the intestine, mesenteric lymph nodes, as well as the fetus, mammary gland and uterus of a 
heavily infected individual. M. paratuberculosis has been thought to be a localized phenomenon limited to the 
small intestine, specifically the ileum and associated lymph nodes. This location predilection is potentially due 
to the distribution of lymphoid tissue within the small intestine of the young calf. In calves, mucosa! lymphoid 
tissue occupies 8.6% of the small intestine, with 1/3 of the total located in the jejunum. The remaining 2/3 of 
the total mass lies in the ileum. 6 
Upon presentation of M. paratuberculosis orally, a limited number of macrophages located in the 
subepithelial and intraepithelial regions will display the presence of this organism within 5 hr. After 20 hr 
many macrophages in the Peyer's patches will demonstrate the bacilli. Once present inside the macrophage the 
bacilli may persist for up to 5 weeks.6 When M. paratuberculosis is mixed and administered with anti M. 
paratuberculosis serum vs. a normal bovine serum, this uptake process is significantly enhanced. The use of 
this antiserum mimics the oral maternal antibody present in colostrum, and thus may start to explain a potential 
familial or genetic link. 1•6 
Recent work has demonstrated the ability of this organism to move systemically, probably due to 
peripheral circulation of GI, non-activated macrophages containing bacilli from the gut associated lymphoid 
tissues (GALT). Extraintestinal sites have been documented which include the uterus, supramammary lymph 
nodes, udder and the sexual organs ofbulls.33 With the intra- and extraintestinal sites in mind the routes of 
bacilli shedding include feces, milk33, colostrum3 and in-utero. 5 Sweeney et al. determined that isolation of M. 
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paratuberculosis from the milk and supramammary lymph nodes was possible in asymptomatic cattle. The 
prevalence of the organism was linked to the amount of fecal shedding. 33 
Realizing that some individual infections may occur prior to oral exposure to this pathogen several 
studies have focused on the possibility of in-utero transmission. The greatest difficulty in performing these 
studies is determination of the true status of enrolled individuals, thus many studies have focused on pregnant, 
clinically apparent dams. A number of studies have suggested that the chances of this mode of spread 
approaches a 20-40% transmission rate in cows with advanced stages of the disease. 5 Work performed in 
asymptomatic cows confirmed the theory ofin-utero spread and documented an 8.6% rate oftransmission.5 As 
can be seen from these figures, the risk increases as the dam becomes more highly infected. Cows confirmed 
positive to late-phase tests such as fecal culture, agar gel immunodiffusion (AGID) and enzyme-linked 
immurmsorbant assay (ELISA) should be considered to be at high risk of delivering an infected calf. A cut-off 
point with respect to fecal culture would indicate that a cow with less than 3,000 colony-forming units (CFU) 
per gram of feces should be considered a light shedder with in-utero transmission being unlikely. It may not be 
necessary to cull this offspring if a program to eliminate post-natal oral infection is successfully implemented. 5 
As a point of reference, cattle in the clinical phase of this infection are capable of shedding bacilli at levels that 
exceed 1010 organisms per gram offeces.4 
Most prevention efforts have centered on the control of infection in young stock, specifically control of 
post-natal infection. The period of greatest transmission risk is during the first six months of life. Some studies 
indicate that 12 months may be required for a bovine to develop adult resistance. The theory that resistance 
increases with age is supported by experimental inoculation work in adults. This class of animal has proven 
more difficult to infect 5. In addition, observational studies of infected environments have shown an increased 
infection rate in calves vs. adults. Horizontal transmission to mature cohorts is possible through fecal 
contamination of water and feed sources, but the complicating factor of adult infection is the long incubation 
period of M. paratuberculosis.34 Current culling rates average 33% with most cows remaining in the dairy 
operation no more than 3 years. Given the incubation period associated with Johne ' s disease it is much more 
likely that the cow will be culled than manifest clinical paratuberculosis. Resistance should not be thought of as 
an "all-or-nothing" phenomenon, rather infection is probably an interaction between dosage and resistance. It 
should be emphasized that clinical disease may be observed in less than 30% of M. paratuberculosis infected 
cattle within a herd. 3 
As with any age group, calves are infected by ingestion of the organism through fecal, milk or colostral 
contamination. 11 Organism exposure frequently is available through fecal contamination, thus the efficacy of a 
post-natal control program is judged on the ability to control this route of contamination. Control of this 
pathogen is highly dependent on the control of the amount of organism exposure. Goodger et al. showed 
through regression analysis (R2 = 0.90) that "high survey scores for environmental conditions, newborn calf 
care, grower calf care, bred heifer care, and manure handling were significantly associated with M 
paratuberculosis prevalence in the state of Wisconsin."86 The following are points that every veterinary 
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practitioner and producer must control to minimize risk. 5 Each dairy is a unique facility and relies on the 
expertise of the practitioner and producer to look at other risk factors beyond this list. 
• Contamination of the calving stall by the dam. 
• Contamination of the calving stall by the previous occupant. 
• Fecal contamination of the udder. 
• Fecal contamination of colostrum or milk. 
• Use of the sick pen as a maternity pen with fecal contamination of potentially clinical cows. 
• Failing to remove the calf soon after birth, thus allowing the calf to nurse the cow, or other cows 
present in the pen. 
• Group housing of cows during parturition. 
• Feeding bunk sweepings from adult cattle to young cattle. 
• Fecal contamination of feeding utensils. 
• Fecal contamination of worker clothing 
• Direct manure contamination of feed (manure in the bunk). 
• Contamination of feeding areas by direct manure runoff. 
• Use of manure handling equipment for feed handling duties. 
A cross-sectional Michigan survey by Johnson-Ifearulundu and Kaneene explored management practices 
as risk factors and calculated the odds associated with each significant practice.24 Their work indicated three 
areas of significant association with increased or decreased prevalence of Johne ' s disease. The first factor 
identified was a 3-fold increase in odds of Johne ' s disease with the use of an exercise lot for lactating cows. As 
this area can be difficult to clean sufficiently, the wet and dirty surfaces may be locations where M 
paratuberculosis can survive and be introduced to the youngstock areas of the farm. Farms that cleaned calf 
hutches and pens after each use demonstrated a 3-fold decrease in odds of infection with M. para tuberculosis. 
The most interesting factor brought to light in this study was the 10-fold decrease in odds associated with 
the application of lime to pasture area. 24 Anecdotal reports exist in the literature suggesting that the application 
oflime to pasture and cattle housing areas seems to be associated with reduction of clinical cases of Johne 's 
disease. Some of these reports also suggested that geographical areas with natural deposits of limestone 
(alkaline and calciferous) have a reduced prevalence of M. paratuberculosis. The potential mechanism of 
action lies in the ability of M paratuberculosis to utilize iron. Iron is needed for bacterial growth, including 
mycobacterial sp. growth. With lime application iron solubility decreases as ambient pH increases, thus making 
iron less available. 
Optimal mycobacterial growth occurs in an in vitro pH range of 5.5 to 6.0 and it would be expected that 
this is consistent in vivo . The pH ofphagocytic vacuoles in the macrophage is 4.5 to 6.0. At this level the host 
iron binding compounds transferrin, lactoferrin and ferritin may provide sufficient iron for mycobacterial 
growth, even in the absence of mycobactin. This could be one of the most significant factors in proliferation of 
this intracellular pathogen in the macrophage population. Soil pH is an interesting theory with respect to 
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mycobacterial survival in the environment, but it may be extremely difficult to prove due to confounding factors 
such as soluble iron levels, calcium concentrations, organic matter levels, soil type, moisture content and 
bacterial as well as fungal residents. While this report is extremely interesting it must be remembered that a 
survey only examines associations, not a "cause and effect" relationship. 24 
It is well understood that a cow with clinical signs of Johne 's can shed billions of organisms each day.5 
While M. paratuberculosis does not readily multiply outside the animal host it will persist in manure, soil, 
manure slurry storage, and manure-contaminated water sources. Best estimates indicate that this organism may 
survive up to a year in manure; moisture and cold temperatures assist survival. 5' 16 With this in mind, all manure 
from Johne ' s positive herds should be considered to be infected and should not be spread on ground that will be 
used as a forage source. The spreading of this material should be limited to row crop areas. 11 
Organism number reduction can be accomplished through the use of commercial disinfectants, although 
the common products are not effective against this organism. Control efforts should concentrate on the use of 
cresylic or phenyl-based products. 11 
One of the greatest sources of transmission to the neonate is feeding contaminated colostrum or milk. 3 
As mentioned with in-utero transmission, the odds of dissemination of M paratuberculosis increase with the 
progression of clinical disease. 5 Dissemination will directly infect the udder tissues with bacilli being liberated 
in both colostrum and milk. Studies of organism shed in milk indicated that 35% of infected, symptomatic 
cows shed through this route, as compared to 19% of asymptomatic heavy fecal shedding cows, and 3 % oflight 
fecal shedding cows. With respect to colostrum, the odds of organism shedding increase by a factor of 2 to 3, 
with 36% of the colostral samples from asymptomatic heavy shedding and 9% of the light shedding individuals 
showing the presence of M. paratuberculosis 5. Milk contamination is a very real risk due to the presence of the 
organism and milk antibody, which enhances bacilli uptake. Colostrum should be considered an even greater 
risk due to increased levels of antibody and mycobacterial shedding.1•6 
Producers have attempted pasteurization of colostrum, but research indicates that M. paratuberculosis 
may survive pasteurization temperatures of 71 .7 C for 15 sec in a water bath. 15 Reports indicate M 
paratuberculosis may be more heat resistant than M bovis, which is one of the reference organisms to defme 
pasteurization time and temperature standards. 15 An additional risk factor of pasteurization is the reduction of 
passive immunity through heat deformation of irnmunoglobulins and loss of the attendant white blood cell 
population of colostrum. Commercial colostral supplements have been tried, but insufficient irnmunoglobulin 
absorption leads to clinical failure of passive transfer to the calf. As colostrum is an essential of successful calf 
raising, the strategy of annual testing of the mature cow herd and timely culling of high shedding individuals is 
a critical step. Despite the antibody test being a late stage indicator of infection some producers will refuse to 
part with cattle that may be productive. In this situation the colostrum from a test positive cow should not be 
used in favor of utilizing banked colostrum from the oldest individual with multiple test negative results . 
With dairy industry consolidation, herds of 500 - 3,000 head of mature cows have become common. 
Even with the contamination potential of both milk and colostrum, most producers are extremely reluctant to 
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discard what they perceive to be a valuable resource. An Iowa producer has purchased an old "small herd" bulk 
tank complete with internal refrigerant piping and agitator. The piping has been connected to a hot water source 
allowing uniform heating of the tank. Following loading, the milk is heated and agitated for 30 minutes with 
the waste milk reaching a pasteurization temperature of 150°F. Research is continuing at this time, but 
preliminary cultures are sterile with respect to Escherichia coli, Salmonella sp., Staphylococcus sp. , and 
Streptococcus sp., as well as Mycoplasma. This has had immediate health benefits for the calf population. 
Additional research will be required to determine if waste milk is currently sterile to M. para tuberculosis, as 
well as following challenge doses to determine the efficacy ofpasteurization.20• 75 
A potential risk factor for the neonate is the phenomenon of the "open gut." During the first 24 hours of 
life the newborn bovine is dependent on the absorption of irnmunoglobulins and white blood cells to establish a 
protective immune system. Failure of this absorption is a failure of passive transfer. During this time the gut is 
"open" to the absorption of macromolecules. It is not know if this possibly includes M. paratuberculosis, but it 
would certainly be conceivable. 5 
Other proposed mechanisms of spread exist. These include semen transmission, embryo transfer, 
transfer from wildlife sources such as deer, and veterinary procedures such as rectal examination. M. 
paratuberculosis has been isolated from semen samples and infected accessory glands of bulls. Inoculation of 
the uterus with infected semen has resulted in infection of the cow. 5 There is no evidence indicating what part 
this has played in the overall transmission of Johne ' s disease. The use of an infected bull in a dairy operation 
should be considered a risk factor and mandates the annual, if not semi-annual testing of these individuals by 
both ELISA and cultural means to enhance testing sensitivity. The artificial insemination (AI) industry tests its 
donor bulls for the presence of the organism, and AI is considered a low risk. 
Dissemination of M paratuberculosis in advanced disease can affect most tissues and uterine washings 
have demonstrated the presence of the bacilli. Thus, embryo transfer could be of concern. Research has 
demonstrated the adherence of the bacilli to the embryo. Given the amount of organism that can adhere and the 
washing techniques performed, this is considered a low risk procedure. Greater risk comes from transfer of an 
embryo into an infected recipient dam. 5 
Deer and other ruminants can be infected by M. paratuberculosis, and could serve as a potential 
reservoir. Deer feces are pelleted, thus minimizing the amount of contamination that occurs over a given area 
of land. Deer are not considered to be a great dissemination risk to cattle, but the "cleaner" a herd becomes the 
greater the risk co-mingling with deer could be. 5 
No studies have been performed with respect to the transfer of Johne's with routine rectal palpations. It 
is not known if the organisms from an individual that is shedding high amounts could penetrate the rectal 
mucosa of a non-infected individual.5 Although this may not represent a great risk, routine sleeve changing may 
benefit in blocking the transmission of white blood cell entities such as bovine leukosis virus . 
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Clinical and Gross Pathology 
Gross lesions of Johne's disease are generally found in the terminal small intestine and associated lymph 
nodes. The ileum will display a uniform corrugated thickening of the mucosa. The mucosa! layers are soft in 
consistency. Gross lesions are rarely seen in the cecum, colon, and rectum. The lymph nodes associated with 
the terminal ileum tend to be enlarged by a factor of 3 to 5 fold, and are edematous and soft. There are no 
lesions suggestive of caseous necrosis, fibrosis or evidence of tubercle formation. The subserosal lymphatics of 
this area tend to be affected as well, appearing dilated, beaded, thickened, and with a tortuous appearance. The 
presence of arteriosclerosis is another sign of advanced J ohne 's disease. 6 
Examination of tissue histopathology indicates a preponderance of epithelioid macrophages in the 
mucosa and submucosa. These will appear without evidence of necrosis despite gross proliferation. 6 The 
Ziehl-Neelsen technique or Immunogold Silver staining reveals large numbers of clustered bacilli in the 
epithelioid macrophages in the mucosa of the affected small intestine. These bacilli are readily apparent in the 
associated lymph nodes as well. The villar tips of the absorptive surfaces of the ileum will appear to be fused, 
and thus contribute to the nutrient malabsorption characteristics of this disease. The granulomatous enteritis 
results in a protein-losing enteropathy and hypoproteinemia. 
Small intestine infection may be described in two ways. Distinct, focal lesions predominate in the 
paucibacillary form. The pluribacillary form is more diffuse and widespread with the lamina propria of the 
intestinal mucosa appearing thickened with numerous macrophage-infiltrated granulomas. Multinucleated giant 
cells can also be evident in the sub-mucosa layer. Similar lesions can be found in the mesenteric lymph 
nodes.35 Using Ziehl-Neelsen staining techniques, many macrophages in the pluribacillary form will display 
reddish clumps and are considered positive. In paucibacillary form these positive macrophages are less evident. 
The multinucleated giant cells will appear unstained. 
Changes in the clinical pathology of the animal are predictable, but can't be used as a diagnostic test due 
to individual characteristics. Most signs are related to the protein losing enteropathy and malabsorption from 
the small intestine. These include reductions in total protein, albumin, triglycerides and cholesterol as the 
disease progresses. Muscle enzymes such as creatine kinase will show elevations as muscular wastage starts to 
occur during the advanced stages of Johne's.6 
Johne's disease can be characterized by four stages of disease.6 They are as follows: 
• Stage I - Silent Infection 
• Stage II - Subclinical Disease 
• Stage III - Clinical Disease 
• Stage IV - Advanced Clinical Disease 
Stage I - Silent Infection. These animals manifest no outward signs of disease, even though they have 
been exposed and infected with M. paratuberculosis. When compared to uninfected cohorts there are no visible 
differences in growth or weight gain. The only means of detecting these individuals is through tissue or fecal 
cultures. To obtain positive results multiple sites would have to be sampled on post mortem. Fecal cultures 
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need to be performed on a multiple basis, and even then affected cattle may be shedding at such a low rate as to 
be virtually undetectable. Detection using antibody or cell-mediated means would be impossible.6 
Stage II - Subclinical Disease. These animals manifest few if any outward signs to distinguish them 
from their cohorts. Depending on the individual host response there may be a possibility to detect these cases 
through antibody or cell-mediated response, but the vast majority are as yet inapparent. A greater number of 
these individuals may start shedding sufficient bacilli to be detected on a fecal culture (15 - 25%).6 Due to 
progressive infection and reduced immunocompentency some of the individuals in this category may be more 
prone to cases of mastitis or other types of infection. 
Stage III - Clinical Disease. The first visible sign at this stage is intermittent or persistent diarrhea. 
This may be accompanied by some weight loss. Depending on the signs and symptoms it may be possible to 
see some changes in clinical chemistry, especially protein values. Animals are not expected to occupy this 
stage longer than 3 to 4 months before progressing to the advanced stage of disease. Physical examination of 
these cows will not yield any abnormalities in terms of vital signs, i.e., heart rate, breathing or ruminations . 
Diarrhea with evidence of blood, mucus or tenesmus should be discounted as being due to Johne's disease. 
Animals at this stage of infection have a good chance of testing positive for the presence of antibody or being 
fecal culture positive.6 
Stage IV - Advanced Clinical Disease. At this stage the physical signs of clinical Johne's disease 
become readily apparent. Due to the protein-losing enteropathy, bottlejaw, weight loss and emaciation are 
readily apparent in addition to the copious, watery diarrhea. This is the terminal stage of the disease and usually 
the point at which cattle are removed from the herd due to low milk production, emaciation, or clinically 
apparent diarrhea and shedding. Dissemination of the bacilli throughout the animal may also occur at this time 
with the result that M. paratuberculosis may be shed through the milk and passed to a developing fetus. 
Affected cattle can progress through stages II to IV in a matter of weeks depending on the host's immune 
response.6 
Immunology of Johne's Disease 
Infection with M. para tuberculosis and subsequent disease is a dynamic event. The progression of this 
disease is not a response to any toxins or substances liberated by M. paratuberculosis. It is mediated by the 
host's immunologic reactivity; thus the course of disease will vary from individual to individual. With this 
dependency on host immune system response, Johne 's has the capability to fluctuate between periods of 
exacerbation and remission. This variability is reflected by the "paradoxical" manner in which cattle infected 
with M. paratuberculosis may respond. Depending on the stage of disease, infections may be characterized by 
cell-mediated response, humoral response, both or neither (anergy). 12• 36• 37 
Immunological variability is the result of at least two factors - the cellular level route of antigen 
presentation in the GI tract, and the opposition of immunological forces, i.e. cellular vs. humoral immunity. The 
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immunology of mycobacterium species is complex, and the experience gained in work with M. tuberculosis and 
M. leprae has direct bearing on the pathogenesis of infection with M. para tuberculosis .12•36•37 
M. paratuberculosis is unique among mycobacteria in its ability to infect the gastrointestinal tract and 
associated mucosal immune system. The resulting immune system response is directly due to the nature of the 
gut associated lymphoid tissues (GALT). GALT is self-contained and compartmentalized, unlike the bronchus 
associated lymphoid tissues associated with M. tuberculosis. The term "self-contained" refers to the ability of 
the GALT to determine its own immune response through presentation of antigen and activation of various 
lymphoid populations. Compartmentalization refers to the resident population oflymphocytes that are derived 
from this area. Lymphocytes from Peyer's patches derivation tend to circulate through the mesenteric lymph 
nodes, into the thoracic duct and into systemic circulation, followed by a return to the lamina propria of the 
intestinal tract. Other than a brief appearance in the systemic circulation these cells are compartmentalized in 
the digestive tract. Due to this compartmentalization, events in the intestinal tract are not necessarily reflected 
in the immune system testing methods available via the peripheral circulation.36 
The paratuberculosis organism is presented to the ruminant through fecal, milk, and colostrum 
presentation of the live organism. After oral ingestion the organism comes in contact with the GALT via the 
micro fold (M) cells. 38 These are antigen transport entities capable of presenting particulate matter such as 
viruses, bacteria (including M. paratuberculosis) and protozoa to the intercellular spaces in the Peyer' s patches 
directly below the epithelial covering. In this area macrophages and dendritic cells phagocytize these antigens 
with subsequent presentation to the underlying lymphocytes of the Peyer's patches. At the time of lymphocyte 
presentation the macrophages are not activated and are not capable ofbacteriolysis.36 
The receiving lymphocyte population can be divided into two categories based on functional role and 
lymphokine profiles. CD4+ type-IT-helper cells (TH 1) produce cytokines primarily consisting ofinterleukin-2 
(IL-2) and gamma interferon (y-IFN) and mediate macrophage activation, delayed-type hypersensitivity (DTH) 
and IgG2a synthesis and are thus associated with cell-mediated immunity (CMI). CD4+ type-2 T-helper cells 
(TH2) produce large amounts ofIL-4, IL-5, IL-6, and IL-10 and mediate antibody production (IgGl and IgE) 
and eosinophilia. 12' 36 Effective defenses against mycobacteria species rely on the active participation of the 
cell-mediated immune system. Production ofIL-4 by T H2 cells acts as a potent antagonist of macrophage 
function, IL-2 receptor sensitivity, IL-2 dependent macrophage proliferation, and production ofy-IFN by 
mononuclear cells. Conversely, IL-4 enhances the production of antibody, which is an enhancement of the 
humoral immune system. Activity of the humoral immune system comes at the expense, or down-regulation, of 
the cellular immune system. 12' 36' 38 
In addition to these populations of lymphocytes another major group of T cells has been identified as 
cytotoxic/suppresser T cells (Tc1,)- This population bears the CD8+ marker. Tc1, cells mediate cytotoxic activity 
and are required for effective immune responses to mycobacteria. The suppressive nature of these cells is 
controversial, and their precise role in mycobacterial infections is not yet clearly understood. 36 
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Early antigen presentation and lesion management is accomplished solely though the GALT with little or 
no stimulation of the peripheral immune system. Two types of T-helper lymphocytes are present. In the GALT 
TH 1 predominates, thus the response is primarily cell-mediated. The normal route of presentation involves the 
M cells presenting particulate antigen into the intercellular spaces of the GALT where the macrophage 
population will have access. The macrophages act as accessory cells and process (prime) the antigen for 
presentation to the lymphocyte population. Priming consists of reduction of the antigen to peptide bases and 
presentation of these bases on the cell surface in conjunction with major histocompatibility complexes (MHC). 
Many cells can present antigen, but the macrophages are uniquely qualified for presentation in a productive 
manner. The result of this presentation is the activation of a primary TH I population with the attendant 
production of the multiple cytokines listed above.12• 36 
Mycobacterial antigen can also be presented in a paracellular route consisting of movement through the 
tight junctions of the intestinal villi with presentation to the lamina propria of the intestine below. Presentation 
in this manner induces the CD4+ population and with it a sub-population ofCD8+ suppresser cells. The CD4+ 
helper response will predominate. Antigen can also be presented through the transcellular route via cellular 
endocytosis. Antigen processing in this manner will stimulate a CDS+ induction with the result that T-
suppresser cells will dampen immune system activity or create a tolerant state. 36• 38 
Upon recruitment, the CD4+ TH 1 population mediates activation of the macrophage population. As 
mentioned earlier, active immunity to mycobacterial infection is dependent on cell-mediated immunity. Cell-
mediated immunity is based on the accumulation and activation of the macrophage population. 12 Unactivated 
macrophages are incapable of bacterial phagocytosis and have reduced antimicrobial activity. Enhanced 
macrophage activities alone are not enough to contain the mycobacterial threat. The T-helper cells must also 
elaborate cytokines which stimulate production of a granuloma site. A granuloma can contain the infection site 
while maximizing bactericidal activity. Critical to the production of a granuloma is the presence of an insoluble 
antigen. The insoluble and complex mycobacterial lipids may be granulomagenic without being 
immunogenic, and persistency is not dependent on the antigens being a living source. 36 Cell fractions or cell-
wall preparations may be sufficient to initiate a granulomatous response.36 
Another manifestation of cell-mediated immunity are DTH reactions as evidenced by skin inflammation 
and swelling following injection of a PPD. It was previously thought there was a direct link between active 
immunity and presentation of a DTH reaction. Study of M. tuberculosis has documented cases in which certain 
fragments of this pathogen are capable of stimulating a strong degree of resistance without the production of a 
demonstrable DTH response. Conversely, injection ofbacille Calmette-Guerin (BCG) in humans showed no 
protective influence while demonstrating a vigorous DTH response. 36 Many of the clinical symptoms seen in 
paratuberculosis and leprosy may in fact be an allergic manifestation. Immunity related to the GALT is well 
compartmentalized and may have very little peripheral immune system exposure. It may be possible to have 
vigorous cell-mediated immunity with little DTH response. Correlation of infectious status with skin testing 
has been poor. 12• 36• 38 
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Discussion of immune system response focuses on the active intervention of this body system. Johne's is 
well known to have periods of time when no measurable immune system activity can be determined by testing. 
Generally this is a late disease phase phenomenon called suppression. Anergy is a form of suppression that is a 
loss of responsiveness or desensitization to a preexisting sensitivity to an antigen. 36 The possible mechanisms 
could include suppression by host serum factors (e.g. , antibody or immune complexes), host cell factors (e.g. , 
CD8+ suppressor cells or cytokines), or bacterium derived factors. 37 The onset of suppression is associated with 
the bacteremia of the late phases of this disease. An example of anergy associated with bacterernia is the 
inability to detect serum antibody. This may be due to immunocomplexing of antibody and free bacteria. 
Another concept of anergy is that it can occur selectively with respect to individual immune system responses, 
such as CMI and DTH. These systems may become unresponsive while the humoral system remains active and 
measurable. Cell-mediated immunity appears to be the only means of actively checking the course of disease. 
Loss, or anergy, of this response allows the bacilli to proliferate at an unchecked rate and frequently signals the 
end stages of clinical J ohne 's disease. A second form of suppression is tolerance, which is the inability to 
respond to initial and subsequent antigen challenges.36 This form has not been demonstrated in Johne's disease. 
One of the last measurable responses in clinical Johne ' s disease is the presence of antibody in the 
peripheral circulation. Antibody has no protective value in the face of a mycobacterial disease, yet tends to be a 
common occurrence in the late stages of this disease. There tends to be an inverse relationship between the 
presence of CMI and the humoral response. This could be explained by antagonistic activity between T 81 and 
T82 type helper cells. Generally, increasing levels ofhumoral immunity signal increased levels of bacteria in 
the affected animal. High levels of circulating antibody should be considered a poor prognosis and grounds for 
removal of the animal from the premises. As mentioned earlier, clinical signs may have an allergic component. 
Immune system complexing with deposition in the kidneys has been demonstrated in humans with infection of 
M. leprae. Similar complexing has been demonstrated in the GI tract of ruminants. This could result in local, 
delayed or immediate hypersensitivity reactions that could contribute to the clinical signs of Johne ' s disease.36 
Immunology and Transmission 
It is well documented that calves ages O to 6 months are the most susceptible to mycobacterial infections. 
In an environment where the prevalence rate is high it can almost be assured that calves will come in continual 
contact with this organism. Examination of early lesions tends to demonstrate multifocal characteristics vs. 
single lesions. This would tend to lend credibility to the theory of multiple exposures and high organism loads 
during the young calfs life. The desire to suck, lick and browse virtually ensures this level of exposure.36 The 
direct form of inoculation is termed exogenous infection. 
Normal means of exposure suggest that the antigen (the bacilli) will come in contact with the Peyer's 
patches of the GALT in the GI tract. M cells then attach the antigen and present it to the population of 
unactivated macrophages present below the epithelium for phagocytosis. GALT macrophages are a 
compartmentalized population. They may circulate briefly in the peripheral vascular system, but they return to 
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the GI tract. Movement of the macrophages carrying intracellular mycobacteriurn progresses from the Peyer' s 
patches to the mesenteric lymph nodes, the thoracic duct, the systemic circulation, and back to the lamina 
propria of the small intestine. 36 There the live bacilli are released to the deep tissues allowing the infection 
mechanism to proceed. This form of hematogenous spread is referred to as endogenous infection. Support for 
this suspected route is the brief seroconversion of young animals early in the course of experimental infection. 
Presumably this is due to the release of bacteria from the unactivated macrophages into the systemic circulation. 
The demonstration of multifocal lesions deep within the lamina propria suggests the only route for initiation of 
these lesions would be through hematogenous spread. 
Vaccination against Johne's Disease 
Vaccination for M. paratuberculosis was first described by Vallee and Ringjard in 1926.42 Their 
observations demonstrated a lack of clinical disease in animals vaccinated with M. paratuberculosis. A product 
is currently licensed for sale in the US that consists of a heat-killed strain-18 M. paratuberculosis suspended in 
mineral oil. Use of this product is generally regulated by individual states. In the state of Iowa a positive 
diagnosis of Johne's disease is determined by an organism based test through the Iowa State University 
Diagnostic Laboratory. A regulatory letter will follow to the submitting veterinarian asking them to contact 
their client about J ohne 's disease and the use of a vaccination program. If the client chooses to go ahead with 
this technique, the producer, practitioner and State Department of Agriculture will enter into a Johne's control 
program, which will mandate one of the choices below.77 At this time there is no formal inclusion of other 
management techniques pertaining to reduction of M. paratuberculosis exposure to young animals. 
1. Culture and cull alone for very lightly infected or recently infected herds. 
2. Culture and cull of adult cattle, with vaccination of replacement heifer calves with a killed whole-
cell vaccine. For herds with a medium infection rate (2%-10%). 
3. Removal of culture positive animals only at first clinical signs, and vaccination of replacement heifer 
calves with a killed, whole-cell vaccine. For herds with a heavy infection rate (>10%), where 
culling all culture positive animals would create a severe economic hardship. 
With permission of the state veterinarian a control agreement is signed and vaccination can begin with 
following provisions. 78 
The Department of Agriculture Agrees To: 
1. Permit use of Johne 's disease vaccine only if herd has clinical history of paratuberculosis and M. 
paratuberculosis has been isolated. 
2. Test entire herd for tuberculosis by the caudal fold intradermal method prior to start of vaccination 
program 
3. Supply vaccine to veterinarian for administration to calves in owner' s herd. 
4. Receive and file vaccination and test records. 
5. Supervise program as necessary. 
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The Veterinarian Agrees To: 
1. Administer vaccine when calf is from 1 to 35 days of age. 
2. Identify calf by official ear tag, tattoo, or registry number and further identify calf with a tattoo in 
the left ear which includes a number representing quarter of year when vaccinated followed by 
letter "J" followed by a number representing the year when vaccinated. 
3. Furnish reports to the Department each time calves are vaccinated, including identification of dam. 
4. Collect and submit samples for fecal culture as requested. 
5. Compensate Department for cost of vaccine. 
6. Issue shipping permits when requested by owner. 
The Owner Agrees To: 
1. Submit no claims against Department, veterinarian, or vaccine producer for losses or adverse 
affects of the vaccine. 
2. Compensate veterinarian for administration of vaccine, collection of fecal samples and laboratory 
culture charges. 
3. Move no cattle from vaccinated herd without a shipping permit or health certificate. 
4. Remove fecal-shedder cattle and clinical cases for slaughter within a time frame mutually agreed 
upon with the State. 
Vaccination produces demonstrable amounts of immune system activity in both cellular and humoral 
areas, yet there is very little functional immunity.36 '42 The vaccine does decrease mycobacterial shedding, 
reduce the number of animals with the appearance of clinical disease, and the number of instances of detectable 
intestinal infection. The vaccine does not, however, prevent infection. 36• 39 .42 Additionally, vaccination nodules 
are a common occurrence with the administration of this vaccine. In one study the injection site lesion rate was 
28%. 40 Administering the vaccine is considered a health risk, and it must be handled with care by the 
veterinary practitioner. Accidental auto-administration has been known to cause granulomatous reactions. A 
study by Patterson et al. examined accidental self-inoculation by veterinary practitioners in the state of 
Wisconsin.41 Their work identified an incidence rate of 1 needle-stick per 1,000 doses administered, or 5.5 
needle-sticks per 100 veterinarians/year of bacterin use. Adverse reactions ranged from small nodules that 
persisted for 4 to 6 months, to painful inflammation of a finger that persisted for 24 months. Despite the human 
risks the vaccine may have a place in herds with high infection rates to reduce culling frequencies. 39• 40• 42 
The producer must bear in mind that the presence of the vaccination program will not be felt for a minimum of 
two years; the time needed for young vaccinates to enter lactation. 
The vaccine benefits listed can most logically be explained using the wealth of knowledge generated 
from the vaccination of humans using the BCG vaccine against tuberculosis. Work in this area suggests BCG 
vaccine inhibits the bacillemic phase of primary infection. 36 This would be the internal bacilli distribution 
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phase. Thus it could be expected that the vaccine provides protection against the endogenous (hematogenous) 
means of infection as compared to the exogenous routes of infection mentioned above.36 
Current technology has focused on the use of whole-cell products, purified antigens and extracts of M. 
paratuberculosis. The most effective protection has been elicited using whole-cell products, which yielded the 
observation that adequate immunity is possibly a result of a host-parasite relationship. This theory has tended to 
be disproven as the antigen and extract products, if properly adjuvented, have achieved demonstrable immune 
system responses ( cellular and humoral). The presence of a CMI response is not the equivalent of protective 
immunity. It has been demonstrated that the cellular cytokines, y-IFN and tumor necrosis factor-a tend to be 
produced as a response to the pathology (the granuloma) vs. the actual organism.36 This would suggest that an 
as yet undescribed antigen may be required to stimulate THI lymphocytes that would result in activation of the 
macrophage population and subsequent organism inhibition and bacteriolysis.43' 42 An optimum vaccine would 
also be able to prevent binding at the small intestine and would thus prevent both means of mycobacterial 
infection ( exogenous and endogenous). 
Research in the area of vaccines continues today, targeting further refinement of the vaccine and the 
potential to produce a gene-deleted product, which could prove beneficial in differential testing of 
vaccinates.43•42 Other research efforts center on moving the vaccine from youngstock to application in adults of 
highly infected herds to reduce total herd shedding at a faster rate than has been accomplished with the 
youngstock program. Rates of culling need to be determined to see if any advantage is present with the later 
application of this product. 
Testing Procedures 
Immune system response measurements can be extremely variable due to the manner in which the 
antigen is presented to the immune system as well as the interaction of individual host responses. One typical 
feature of this disease, if anything can be called typical, is that animals in early infection stages rarely mount a 
measurable immune system response. There is a period of anergy prior to the time that any response, cellular or 
humoral, can be measured. Some transient measurements are possible as M . parartuberculosis passes through 
the digestive tract ( cultural) or exposure to the peripheral circulation occurs (humoral), but these are not 
repeatable. At the first stages of repeatable, measurable immunity, bacterial counts are likely to be greater than 
104 CFU within each of the multifocal lesions. 36 
Patterns of measurable response will vary from animal to animal, but in the early stages of infection the 
cell-mediated phase tends to predominate due to active proliferation and differentiation of T cells. As the onset 
of clinical signs approaches, the measurable systemic reaction will shift to a predominantly humoral (antibody) 
response. The cell-mediated phase will decline as the humoral response increases. In the final stages of disease 
the animal may lapse again into a period of anergy as both cellular and humoral responses diminish. 12 
With this response variability in mind, a rule of thumb known as the "Iceberg Effect" can be applied to 
determine the effects of Johne's disease on a particular operation. The "tip of the iceberg" is the advanced case. 
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For every "home-raised" (reflects young stock management) advanced clinical case there are potentially another 
25 cases at some level of infection. Only 15 - 20% of these cases may be detected using current testing 
procedures. Using the staging procedure listed above, the following is the possible breakout distribution of 
these cases. 6 
• Stage IV - Advanced Clinical Disease ......... ............ ... .... ... .. ..... 1 animal 
• Stage III - Clinical Disease ... .... .. ...... .. .. ...... ..... ..... ....... .... .... .... . 1 - 2 cattle 
• Stage II - Subclinical disease: carrier adults .......... ........ ........ ... 4 - 8 cattle 
• Stage I - Silent infection ( calves, young stock and adults) ...... . 10 - 14 cattle 
• Total ......... .... .. ............... .... .... ...... ... ...... ......... ..... ..... ... ....... .. ...... 15 - 25 cattle 
Multiple testing means are available to the practitioner for determining the presence of Johne's. These 
include: four means of organism detection and/or isolation, four means of antibody assay, and two assays for 
the presence of a cell-mediated response in the form of y-IFN determinations, and a DTH skin reaction.21 Most 
testing procedures are most sensitive in detecting the presence of Johne's in animals that are in Stages III 
to IV.44 
Current testing means have frequently been criticized by the cattle industry as being too insensitive to be 
of any value. The intracellular location and slow, progressive nature of the disease is most responsible for this 
criticism. 17 While the goal of the veterinary profession is to find a means of increased sensitivity there is often 
great producer reluctance to use test information to remove identified individuals due to milk production, 
genetic potential or the lack of any apparent disease. This is true even in the face of testing means that 
demonstrate a false positive rate of less than 1 %. Given the variability in disease presentation due to immune 
system unpredictability, sensitivity rates approaching 50% may be very good. Another factor for consideration 
is that once an animal starts to move to late phase clinical disease the tests available perform at levels very 
similar to available tests for other infectious diseases. 2 1 
Organism Detection 
Bacterial culture is one of the oldest, most reliable forms of testing available. It is often considered the 
"gold-standard" in detection and can be performed on both feces and tissue cultures from biopsy samples or 
post mortems. The advantage of this test is its specificity, which is 99.9%. This method of testing should not be 
used as the sole diagnostic means due to the intermittent shedding of M. paratubercu/osis . With this in mind, 
sensitivity of this test runs 45% to 50%.4 Bacilli isolation is a true indicator of animal shedding and is good 
evidence for removal of identified individuals. The disadvantage lies in the slow bacillus generation time of 4 
days for M. paratuberculosis. Typically these cultures take up to 16 weeks for completion during which time 
the practitioner risks losing producer interest. Additionally, cultures tend to cost $16 to $20 and are subject to 
fungal contamination which renders them unreadable. 
While this method of testing is widely used, the proficiency oflaboratories can vary widely. Techniques 
in test sensitivity improvements have included organism concentration and growth media. All samples for 
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culture must be decontaminated prior to culture. Most commonly this is performed using hexadecylpyridinium 
chloride (HPC), a disinfectant considered to be the least hannful to M. paratuberculosis while rapidly killing 
other species.21 HPC has no affect on fungal contamination. The samples are then concentrated using 
centrifugation, sedimentation or filtration to increase the amount of M. paratuberculosis present for inoculation. 
Paradoxically these concentration efforts may also result in increased amounts of contamination. Typically this 
is addressed through pre-incubation in broth media incorporating antibiotics (Cornell method, and NADC 
method) or the inoculation ofHerrold's egg yolk media containing antibiotics.45 Most laboratories use 
Herrold's media, but there is no commercial source, again hampering standardization. Typically 4 slants of 
Herrold's are inoculated to maximize the chances of having a readable culture if fungal contamination is 
present. 
A study by Whitlock et al. examined the current practice of using single or limited numbers of fecal and 
tissue cultures as compared to the odds of finding M. paratuberculosis growth from an infected animal.46 The 
authors widened their scope of tissue cultures to include the pulmonary, mandibular, retropharyngeal, hepatic, 
supramammary, ileal-cecal and mesenteric lymph nodes, as well as multiple sites through the jejunum and 
ileum. Their conclusions indicated that fecal culture remains one of the most sensitive testing means available, 
but most infected cattle will only be detected after multiple, serial cultures. Some cattle will remain undetected 
until examination at slaughter; 30% of the cattle with repeated negative fecal cultures were tissue culture 
positive at post mortem examination. 
The authors also indicated that tissue culture methods were a more sensitive means of detection as 
compared to histopathological examination looking for macrophages, giant cells and epithelioid cells with acid-
fast bacilli in a granulomatous response.46 Current diagnostic practice suggests that tissue culture of the ileal-
cecal lymph nodes and ileum should be performed as an adjunct to histopathological examination. Given the 
results of multiple tissue samples, the authors also suggested that current culture practice may misdiagnose 
approximately 20% of the cases currently declared negative. The study found that disseminated infection 
occurs frequently in cattle with Johne 's disease, especially in the later stages of infection, but it can also occur 
as early as the subclinical phase. 
A Netherlands study by Kalis et al. examined a test and removal program utilizing fecal cultures every 6 
months.47 Their work demonstrated that the second 6-month test period was less successful in the identification 
of positive individuals. The majority of infected cows identified in the third period took greater than 6 months 
to excrete a detectable number ofCFU. This work could be an argument for fecal culture test intervals of not 
less than 1 year in length. As a part of this study, fecal culturing was extended to younger members of the 
enrolled herds. No heifers <11 months of age cultured positive, while a significant increase in culture positive 
results was recorded in heifers 13 to 14 months of age (5.9% positive). Like the heifers< 11 months of age, 
heifers> 14 months demonstrated significantly fewer culture positive individuals as compared to the 13 to 14 
month old population. This would support the observation that fecal shedding can occur in an early phase of 
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bovine para tuberculosis, followed by a phase of silent infection not detectable by fecal culture. 47 These culture 
results also raise the question of horizontal transmission among heifers housed in less than sanitary conditions. 
A modification to the fecal culture technique is the commercial culture kit known as the BACTEC 
(Bentson Dickson Laboratories, Inc., Sparks, MD). Inoculations are made into a liquid media (BACTEC 12 B) 
that contains a radioisotope-labeled nutrient source (1 4COrlabeled palmitate). Growth of the organism is 
detected using an analytical device that measures 14CO2 released by bacterial metabolism. This technique has 
been combined with a filter concentration technique of M. paratuberculosis to yield more rapid isolations ( 4 to 
7 weeks) along with increased sensitivity. Growth may be detected as early as 9 days post-inoculation on 
severely infected animals.48 This testing method is not currently in widespread use. 21 
The specificity for this culturing technique is estimated at 99.9%. While this specificity is very high 
there does exist the detection risk of"pass-through" isolations.49 In heavily contaminated environments, bacilli 
may be presented to the animal with the result that organisms are "passed-through" or shed. These individuals 
could possibly show a false positive isolation, but given the sensitivity of this testing method at 45% to 50%, 
the risk is very low. This risk could become a greater concern with the development of increased sensitivities in 
fecal testing. 
The third form of organism detection is performed using the DNA probe method. This is a very rapid 
detection technique and depends on the test identification of the insertion sequence 900 (IS900) that is present 
in 15 to 20 copies per organism.50 This insertion sequence is thought to be unique to M. paratuberculosis. 
Detection of the IS900 is dependent on gene amplification techniques such as PCR. Even with amplification 
this test remains somewhat less sensitive than culture since the concentrations of M paratuberculosis must 
approach 104 organisms per gram of feces for detection. Current culture techniques can detect as low as 10 to 
100 bacteria per gram offeces.51 
Van Der Giessen et al. suggest that the majority of animals shedding M paratuberculosis will be missed 
by the PCR technique.51•52 Their work has demonstrated that PCR can detect chromosomal DNA down to a 
level of 2 to 3 bacteria, which is the equivalent of 50 bacteria per gram of feces. The potential reason this 
testing method is not performing at this level could be due to the presence of inhibitors in the fecal samples. 
Removal of these inhibitors may hold the key to routine DNA probe use. 
A recent concept being tested to remove contamination is the use of glass or latex immunomagnetic 
beads. The beads are coated with antibody specific for M paratuberculosis. The fecal sample and water are 
placed in a glass vial containing the beads. The contents are shaken, and a magnet is applied to the outside of 
the vial to hold the beads in place. The feces are removed and the beads are washed to remove fecal inhibition 
factors . The PCR technique can then proceed. This concept is currently used to detect E. coli O 157 :H7 from 
fecal samples. 53 
In studies by JR Stabel's laboratory (National Animal Disease Center -Ames) the commercial DNA 
probe was found to identify only 60% of the isolates that were determined as positives by fecal cultures. Recent 
work has focused on combining two amplification steps in the PCR, thus increasing the sensitivity to 50 
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organisms/gram of feces vs. 104 organisms/gram. The number of manipulations currently required for the 
second amplification step limits the utility of the two-amplification probe. 50 
The power of the DNA probe lies in its speed. From start to finish this organism-based test requires only 
3 days to complete, and, no confirmatory testing is required for organism identification as IS900 is considered 
to be diagnostic at this time.50•5 1 Sensitivity for this procedure is approximately 35%, while specificity is 
99.9%. An additional benefit over culture based testing is that no samples are lost to fungal contamination. 
This form of testing can be difficult to run, and the accuracy of the technique varies with the laboratory. False 
positive results can occur if gene products produced in a lab are allowed to contaminate samples. Due to 
current sensitivity constraints, some labs are limiting this test to use as a rapid means of cultural identification. 
The fourth method of organism detection is the use of histopathology and immunohistochernistry 
techniques of prepared tissues. Tissues are acquired from post mortem samples or from surgical biopsies of 
genetically high merit animals. Tissue changes and bacteria are detectable in the intestinal lining and adjacent 
lymph nodes. Generally animals in the early stage of infection, such as Stages I or II, are not detectable by this 
method, with the result being a false negative.44 The reader is referred to the section on Clinical and Gross 
Pathology for a more detailed explanation of the tissue characteristics of Johne 's disease. 
Work by Coetsier et al. focused on the creation of polyclonal and monoclonal antibodies to a 
recombinant polypeptide (a362), which carries M. paratuberculosis species-specific epitopes.35 These epitopes 
are not cross-reactive with any other mycobacterial species, and would be extremely useful for tissue staining 
techniques. This procedure demonstrates advantages over the routine Ziehl-Neelsen staining technique. These 
include: 1) increased sensitivity, 2) detection of M. paratuberculosis infection in both paucibacillary and 
pluribacillary forms of the disease, 3) Ziehl-Neelsen staining only detects bacilli with intact cell walls, while 
immunohistochernistry can detect fragments, and 4) the technique can be performed on fixed tissues. An 
additional benefit is evident when compared to PCR identification which is not capable of detecting 
intracellular M. para tuberculosis . This method of immunohistochernistry can localize these organisms. 35 
Antibody Assays 
Antibody assays for the detection of Johne ' s disease have been an area of serious work starting first with 
the complement fixation (CF) and agar gel immunodiffusion (AGID or Rapid Johne ' s Test, ImmuCell, 
Portland, ME) techniques. Development and improvement of the ELISA has made it the standard for antibody 
detection in bovines.21 Unfortunately most antibody production occurs during the late phase of disease, and due 
to the slow, chronic, and progressive nature of Johne's most animals are in a pre-clinical phase of disease when 
tested. This makes antibody detection a later phase test than the industry would like. 54• 55 
As M. paratuberculosis enters the peripheral circulation during dissemination of the organism, B-
lymphocytes become activated to produce antibody. Antibody does not exert a protective influence, but can 
serve as a marker element for the presence of this disease. As this is a circumstance of dissemination, antibody 
is a late phase marker of this disease, as is the liberation of significant amounts of organism in the feces 
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allowing cultural detection. Although a late phase response, the presence of antibody may be the first signs of 
clinical disease, thus allowing the practitioner and producer to cull animals while they still have market value.21 
Sensitivity in these types of tests is dependent on the analytical sensitivity or concentration of antibody 
needed to tum the test positive. It is also a measure of the percentage of M. paratuberculosis infected cattle 
within a herd with positive test results.55 Currently the ELISA test is the most sensitive with an aggregate 
sensitivity of 45 .5% ± 6.7%, with a specificity of 99.7% ± 0.3%.56 Work by Collins et al. demonstrated that the 
antibody concentration in low-level shedders may allow sensitivities of only 24.6% ± 10.2%, while use in 
animals displaying clinical signs may have a sensitivity of 88.2% ± 5.5%.55' 56 With this in mind, a practitioner 
performing a whole herd test should assume that the ELISA means of testing, as a general rule, will under-
report the actual prevalence by 50%. 
While making an estimation of herd prevalence a practitioner should keep in mind that aggressive culling 
following detection may cause severe under-estimation of the actual rate. AGID and CF testing method 
sensitivities are in the area of 18.9% - 26.6% and 10.8% - 31.1 % with specificities approaching 99.4% - 99.9% 
and 90.3% - 97.4% respectively.57' 18 The positive predictive value of the AGID is very high, but due to its low 
sensitivity it should not be considered as the test of choice for herd screening purposes.27 The AGID test is 
useful for the detection of Johne's in individuals exhibiting weight loss and/or diarrhea. In these cases the 
sensitivity of this test is 96.9% with a specificity of94%. 
The CF test is required by many countries for import/export regulations, but with many false positives 
and false negatives, CF is not recommended in the US for routine diagnostic use.44 Complement fixing 
antibodies are a relatively late phenomenon in the course of Johne's disease. It has been reported that CF 
reactivity is associated with persistent fecal shedding of M. paratuberculosis . Animals that shed few or no 
organisms in the feces are negative to CF testing. 58 
Specificity is determined by the percentage of noninfected cattle having negative test results for the 
presence of M. paratuberculosis. One of the major criticisms of the ELISA technique has been the lack of 
specificity. This has been addressed with the refinement of antigens and the removal of cross-reacting, non-
specific antibodies. The ELISA test currently utilizes an extract of M. phlei as a preabsorption agent to increase 
specificity. 16' 55 With these refinements antibody test specificities are greater than 99%.21 Determination of 
specificity can be elusive with Johne's disease. Due to the long incubation time some M. paratuberculosis 
infected cattle may be emolled in the presumptive noninfected group. 55 Additional criticism was leveled at 
antibody tests suggesting that positive results were false since fecal culture testing of the individual was 
negative. With the determination that antibody production can precede fecal shedding, this criticism has been 
removed. 
Due to the sensitivity and specificity of the ELISA this procedure has become one of the regulatory 
standards in the US. The major breakthrough in this testing procedure came with the preabsorption treatment of 
sera with Mycobacterium phlei which removes cross-reacting mycobacterial antibodies.55 The USDA licensed 
kit is the absorbed ELISA (IDEXX Laboratories, Inc., Westbrook, ME). The arrival of this test has been 
26 
advantageous in the standardization of procedures and results among laboratories. In addition to these benefits 
test results are now reportable in a quantitative manner. The use of optical density values to calculate a sample 
to positive ratio (SIP ratio) provides real advantages for the practitioner and producer in identifying and 
prioritizing animals with the greatest response.59 Increased antibody response generally means that the animal 
is in greater danger of becoming a clinical case. With that in mind a list can be developed of tested animals 
within a herd that should potentially be culled or immediately retested. Work by Sweeney et al. suggested that 
reference negative cows they tested were consistently below the recommended cutoff SIP ratio of 0.10, while 
infected cows were broadly distributed on both sides of the 0.10 cutoffvalue.56 To maximize specificity, while 
retaining reasonable sensitivity, the IDEXX test utilizes a cutoff SIP ratio of 0.25. Recognizing the gray zone 
between 0.25 and 0.10, Dr. Michael Collins developed a grading procedure to help the practitioner and producer 
in assembling a prioritized action list (Table 1 ). 60 The graded test allows identification and inclusion of animals 
that just missed the positive designation. The practitioner may then elect to target these animals for additional 
testing at a later date. 















Retest in 6 mo. 
Infected - early stage 
Infected & shedding 
Soon to go clinical 
Sweeney noted that disease progression is linked to diminished response of the cell-mediated immune 
system. The onset of the humoral response and increased fecal shedding makes clinical cases more easily 
detectable. The risk of fecal shedding thus increases as the humoral response increases. Serodiagnosis with the 
ELISA method is not useful in detecting animals prior to shedding detectable M. paratuberculosis in the 
feces. 56 A test procedure that would detect a positive animal preshedding would be of great utility. 
When used to test the same serum samples, the ELISA test agrees very well with the CF and AGID 
testing methods (K > 0.5). When compared with tests that detect M. paratuberculosis in feces the level of 
agreement is lower. The low K statistic of 0.36 suggests that the ELISA test is selecting a different population 
of infected cattle than the fecal culture test. This stands to reason as fecal culture is detecting the organism in 
the feces, while the ELISA is detecting the event of antibody production. 57 With this in mind the ELISA test 
can be used in a parallel manner with fecal culture to increase the detection sensitivity. This sensitivity increase 
would come with the premise that a positive on either or both testing means would be considered a positive 
designation. Collins et al. suggest combination sensitivities may approach 69%. 55 
A relatively new advance in ELISA testing is the introduction of the Tip-Test® (ImmuCell, Portland, 
ME), a rapid, simple Johne 's diagnostic test designed to be run in the veterinary practitioner's office.18•84 The 
basis of the test is a pipette tip packed with cellulose in a 3-stage filter. A plasma or serum sample is run 
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through a series of solutions that are provided in the test kit, and then aspirated into the test tip. The two upper 
sections of the cellulose media are positive and negative control areas. The lowest section is for sample color 
determination. The cellulose capture area is a unique development. The large amount of surface area available 
maximizes the test area to sample volume ratio, thus improving the test sensitivity. The test can be performed 
as a single animal test or up to 12 tests can be run simultaneously using a 12-channel pipetter. The total time 
required to perform this test is 25 minutes. The sensitivity of the Tip-Test® is similar to the commercial ELISA 
test available to diagnostic laboratories ( 45% ). 18•84 Of 40 animals with clinical signs of Johne 's the test detected 
95.2% of the positives. Of 28 individuals that were fecal and tissue culture positive while having no signs of 
clinical para tuberculosis the test identified 57 .1 % of the positive animals. Further testing indicated an 86. 7% 
specificity, or a 13.3% false positive rate. 
While the Tip-Test® brings Johne's testing directly to the practitioners office there are some concerns. 
The Tip-Test® is licensed as a test for clinical cattle only. Some states may elect to ban the use of this test all 
together to eliminate any regulatory confusion within state boundaries. The Tip-Test® is a color change test, 
which leaves some gray zone for individual interpretation by the practitioner or technician performing the 
procedure. Additionally, the lack of an optical density reading and no calculation of an SIP ratio will limit the 
practitioner and producer in following the course of disease of any individual animal or allowing comparison 
with herdmates. Conversely, the Tip-Test® may have great utility in obtaining "same-day" results for making 
individual cow culling decisions. 18•84 
Serum is not the only location where antibody is present; milk is another readily available source. Most 
of the IgG in milk originates from serum, although some may be produced locally in the mammary gland. Thus 
the concentration oflgG in milk is proportionate to serum IgG.61 The ELISA test can be adapted to process 
milk as a sample and this means of testing is readily available through some dairy milk laboratories. The 
advantages of this procedure are convenience of collection and the minimization of stress to the cow. 61 
Initial reports of milk ELISA results have not been encouraging. Hardin demonstrated that the ELISA 
test procedure for milk did not agree with the results from serum ELISA determinations (kappa= 0.076).61 
Additionally there was little agreement between the two tests in the determination of the herd test prevalence 
rate or test positive percentage (R2 - 0.1077). Due to these discrepancies determination of individual culling 
decisions or herd test prevalence rates should be performed using the serum ELISA. An additional unanswered 
question Hardin raised was how the factors of milk quality and quantity impacted the correlation between the 
serum and milk ELISA tests. 
Sweeney et al. used a milk ELISA containing lipoarabinomannan (LAM) antigen. 62 Their work 
determined a specificity of 87% ± 8 .1 % when the sensitivity cutoff was set at 50%. When the cutoff was raised 
to 60% the specificity dropped to 83% ± 9 .1 %. The predictive value of a positive test using these values for 
sensitivity and specificity offers only a 29% chance that a positive test is correct. This value is too low to be 
considered for culling purposes. 
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Determinations of Cell-mediated Immunity (CMI) 
The first response by the infected individual is mediated by activated T-lymphocytes. This is reflected 
by DTH reactions, and the release of cytokines such as y-IFN. Skin testing, or DTH is the traditional means of 
tuberculosis detection in both humans and cattle and has been successful. Thickness of the skin is measured at 
injection and again 72 hr post-inoculation, with any change >5mm considered to be a positive reaction. 
Unfortunately, the close association of M. paratuberculosis and M. avium and the presence of environmental 
mycobacterial species may preclude a definitive diagnosis of M paratuberculosis infection. This testing 
procedure has been criticized for the high number of potential false positive reactions. 12 
If poor sensitivity and specificity weren' t enough to create murky results, a study by Wentink et al 
demonstrated strong hypersensitivity reactions in the face of lower levels of intestinal infection of M. 
paratuberculosis and evidence of degenerated bacilli in the macrophages.4° Conversely, a weak reaction was 
associated with high levels of gut infection and viable M. paratuberculosis in the macrophages. Other 
researchers suggest that DTH reactions may not be a good representation of cell-mediated activity located in the 
distant gut area, again due to poor sensitivity and specificity. 12 Due to their long history, the johnin 
(paratuberculosis antigen) skin test and IV johnin tests still have applications in some international trading 
procedures. Given the efficacy of some of the testing methods previously mentioned the use of these testing 
means should be limited to mandatory regulated uses. 21 
A testing means that merits mention as a research tool, but not as a practical animal test, is lymphocyte 
blastogenesis measures of lymphocyte proliferation after incubation with M paratuberculosis antigens. 
Radiolabeled nucleic acids are incorporated and included in the DNA following mitotic division of stimulated 
lymphocytes. The degree of incorporation is measured to indicate the amount oflymphocyte reactivity 
encountered. Like the DTH test, this measure lacks sensitivity and mycobacterial species specificity. 
Additionally isolating lymphocytes is labor-intensive and the procedure requires long incubation times. 12• 14 
The most recent work in CMI determination uses the y-IFN enzyme-linked immunoassay (EIA). 12 By 
testing an earlier phase response this procedure holds promise of detecting earlier infections of M. 
paratuberculosis, identifying infected individuals prior to, or during early shedding, and potentially allowing 
detection in younger cattle. ELISA testing is not valid in sheep or goats. Testing methods for these species 
have centered on the use of the AGID test with its attendant lack of sensitivity. The y-IFN EIA can be used in 
sheep and goats and may represent a step forward in combating Johne's in these species. 
Activation of the macrophage population to become antimycobacterial is highly dependent on the T cells 
and their secreted products. Gamma-interferon is secreted by CD4+, CD8+ and y/8 receptor T cells and natural 
killer cells, and is responsible for inducing macrophage tumor cell lysis, release of reactive oxygen and nitrogen 
intermediates, expression of major histocompatibility complex class II antigens, and secretion of arachidonic 
acid metabolites. With this pattern of activation there is a direct link between y-IFN production and activation 
of the antimycobacterial macrophage population. 12 
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The logistics of the y-IFN EIA can be challenging as the test must be performed on live lymphocytes 
from a fresh blood sample collected in sodium heparin. Collection in sodium citrate or EDTA will negate the 
production of y-IFN. 14 The sample must be delivered to the lab within 16 hours after collection to ensure a live 
lymphocyte population. For protection of the lymphocyte population the samples should be stored at 25 C. The 
samples should not be refrigerated. 14 The usual procedure is to divide the blood sample into 1-rnl aliquots 
incubated with stimuligens. One sample remains unstimulated to serve as a negative control. The viability of 
the lymphocytes is determined through stimulation with a mitogen as a positive control. Other aliquots are 
stimulated with antigens to M. avium and M paratuberculosis. After incubation the plasma is harvested and 
processed using an ELISA technique specific for the detection ofy-IFN. Samples that display a positive optical 
density value >0.1 units over the non-stimulated control are considered to be positive. If the M. avium optical 
density is greater than or equal to the M. paratuberculosis response, the animal is considered positive due to 
environmental exposure. Wood et al. suggested that M. avium sensitivity in cattle is often transient, whereas 
reaction to M. paratuberculosis infections tends to be persistent. 63 Repeated testing would allow construction 
of a profile on individual animals to distinguish this cross-reactivity. Once plasma is harvested from the 
stimulated sample it may be stored for up to 1 year at -20 C or up to 2 months at 4 C under sterile conditions. 14 
An aspect of the current dairy expansion is an increase in individual stress and its impact on y-IFN 
testing. Decreased lymphocyte response to rnitogens has been demonstrated under conditions of stress. A trial 
was performed to determine if dexamethasone administration could suppress the y-IFN response of cattle tested 
for reactivity to M bovis antigen. As early as 24 hr following the first dexamethasone injection a decline in y-
IFN was recorded. Parturition, shipping- and production-related stresses are associated with the release of 
endogenous cortisol. While dexamethasone is a more imrnunosuppressive glucocorticoid than is cortisol, stress 
may well be a factor that practitioners will want to keep in mind with respect to cell-mediated testing 
procedures. 64 
A study by Thoen and Waite demonstrated decreased delayed type hypersensitivity reactions to M. 
paratuberculosis for 7 days following exposure to modified-live Bovine Viral Diarrhea vaccine (ML-BVDV).29 
Decreased lymphocyte blastogenesis was observed during this period. Previous work also suggests that 
lymphocyte responses to phytohemaglutinin, polkweed rnitogen, and concanavalin A were altered, which could 
have a direct bearing on the efficacy of the y-IFN EIA. Simultaneous testing showed no decrease in ELISA 
responses by affected cattle. Information from field investigations also suggests that increased levels of clinical 
Johne ' s disease have been observed in herds that have experienced clinical BVD. Given the frequency ofBVD 
outbreaks in cattle concentrated in expansion herds, the practitioner will want to keep this in mind ify-IFN EIA 
comes into widespread use.29 
A study by Wood et al. 1991 tested 6 herds infected with Johne's disease.63 The testing methods 
included the y-IFN and absorbed ELISA assays. Verification oftest results was performed on diseased cattle 
removed from the herd through the use of fecal culture and histopathological examination of the tissues 
collected at post mortem. Gamma-interferon was equally sensitive in detecting subclinical (71.8% to 93.3%) 
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and clinical animals (100%) whereas the absorbed ELISA was more sensitive in detecting cattle with advanced 
infections (80%) than those with subclinical infections (20.5% to 26.6%).63 ' 65 Work by Bilman-Jacobe et al. 
suggested that the specificity was 97.6% for the y-IFN EIA.65 
Testing Summary 
Current arguments surrounding the testing, culling and control of Johne 's disease suggest that organized 
control efforts should wait until a better test is found. Test sensitivities and specificities are approaching 50% 
and 99%, respectively. Different modes of testing are available, such as detection for antibody, organism and 
cell-mediated responses. Using more than one test at any given sampling period is considered to be parallel 
testing which increases the sensitivity.66 Collins et al. suggests that use of the ELISA, Bactec and y-lFN tests 
together will increase sensitivity levels to 97%, while specificity approaches 99 .9%. 67' 34 Increasing the 
frequency of testing within a herd will increase specificity, again to levels approaching 99.9%. The real 
question that remains is, do we as practitioners and producers have the will and financial reserve to cull the 
animals that are indicated as positive by these testing means. 
Collins and Morgan designed a spreadsheet program to perform a decision tree analysis for the control of 
paratuberculosis.68 Their findings indicated that a test and cull program was profitable if Johne's disease caused 
a 6% or greater decrease in milk production. A herd prevalence of greater than 5% suggested test and cull 
profitability. This strategy was based on 50% sensitivity and 98% specificity, with test cost being $8 or less per 
cow. Parameters considered also included $1,000 for a replacement animal, average cull weight of 556 kg and 
a cull price of $40 to $45.5 per kg.68 
Test selection depends on several factors which include test cost, time to run, sensitivity, specificity and 
stage of disease that can be detected. Table 2 shows a summary oftest specifics.44• 55 
Predictive Values of a Positive or Negative Test 
Veterinarians are frequently questioned concerning their confidence in test results. The client can be 
given a more precise evaluation through calculation of the predictive value of a positive test and the predictive 
value of a negative test. This information can be gained through the use of three statistics, which include the 
sensitivity (SE), specificity (SP), and best estimate of herd prevalence rate (P).69 
Estimated prevalence (EP). The first step is estimation of herd prevalence. The estimated prevalence 
is based on the veterinarian' s knowledge of the herd history of confirmed cases of Johne ' s disease. This 
confirmation would be on the basis of fecal culture, histopathological examination, or evidence of Johne's-like 
lesions on post mortem. A rule of thumb is, for every cow out of a hundred confirmed per year with Johne's 
disease the prevalence rate may be between 5% and 15%. This is a very rough estimation, but it provides a 
starting point. 69 An alternative method would be to use the NAHMS survey overall prevalence rate value of 
3.4% and adjust up or down based on history, and/or new data.7 
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Table 2. Johne's Disease Test Specifications 
TEST Cost Time Sensitivity Specificity Stage 
Detected 
Fecal Culture $16-$25 12- 16 40%± 10% 99.9% Late II - IV 
weeks 
Fecal Bactec $16 - $25 7 weeks± 2 54.5% ± 7.3% 99.9% Late II - IV 
DNA Probe $25 - $45 3 days 33.5% ± 6.9% 99.9% III - IV 
Histology $6-$12 3 davs 20%? 99.9% III - IV 
CF Test $3 - $6 2 days 26.6% ± 6.5% 97.4% - 90.3% Late III - IV 
AGID $3 - $6 2 days 18.9% - 26.6% 99.4% - 99.7% Late III - IV 
Serum ELISA 
subclinical to $3 - $6 2 days 18%- 85% 96% - 99% Late II - IV 
clinical 
Serum ELISA $3 - $6 2 days 45.5% ± 6.7% 98%- 99.7% III - IV Aggregate 
Serum ELISA $19 - $31 12- 16 & Fecal 69% 99.5%+ Late II - IV 
Culture Parallel Testing weeks 
Milk ELISA $5 - $8 2 days 50% 87%±8.1% III- IV 
Milk ELISA $5 - $8 2 days 60% 83% ± 9.1% III- IV 
y-IFN $16 - $25 3 days 71.8% - 93.3% 97.6% II-IV 
subclinical 
y-IFN clinical $16 - $25 3 days 100% 97.6% III-IV 
Johne ' s Skin $2 - $5 3 days 54% 79% II?-IV Test 
Apparent prevalence (AP). This statistic is based on the application of a whole herd test and is the 
number of positive animals divided by the total number within the herd. This figure alone will be a better 
measure of prevalence, but it is not adjusted for the sensitivity of the _testing method. As the aggregate 
sensitivity of the ELISA method is approximately 45%, the apparent prevalence rate could legitimately be 
doubled to give a more accurate assessment of the true prevalence rate. If the test in question has a lower 
sensitivity, such as 35%, the AP could realistically be multiplied by a factor of 2.5 to 3.0.69 
True prevalence (TP). Following determination of the apparent prevalence the TP can be calculated 
using the sensitivity and specificity of the whole herd test utilized to generate the herd data. The formula is as 
follows: TP = [AP+(SP-1)]/[SE+(SP-l)]. An example would be a herd that has an apparent prevalence rate of 
8% following a whole herd fecal culture test. Using a sensitivity of 40% and a specificity of99.9%, TP = 
[0.08+(.999-1)]/[.40+(.999-l)]. TP is equal to 0.20 or 20%.69 
The sensitivity (SE) of a test is the ability to detect a positive animal with a positive test result, while the 
specificity (SP) is the determination of a negative animal with a negative test result. If test sensitivity is low, 
there will be a larger number of false negative responses . Conversely, a high test specificity will yield fewer 
false positive determinations. 17'69 Most Johne's testing procedures tend to have high specificity in an effort to 
reduce the number of animals falsely incriminated. 
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Using an ELISA test as an example, there are two possible outcomes for any individual test, either 
positive or negative. This does not reflect all possibilities, as the result could also be a false positive or a false 
negative. To be properly informed the producer needs to be aware of the chances of a positive or negative 
determination being truly positive or negative. Having gained an estimate of prevalence above, the predictive 
value of a positive test (PVP) can be generated. Following is the formula for this determination: PVP = (SE x 
TP) I ((SE x TP)+((l-SP) x (1-TP))). Using a sensitivity= 45%, specificity= 98% and a true prevalence= 
10%, the formula would be as follows: PVP = (0.45 x 0.10) I ((0.45 x 0.10)+((1-0.98) x (1-0.10))).69 The PVP 
would equal 71.4%, meaning that a positive test had a 71.4% chance of being a true positive or a 29.6% chance 
of being a false positive. 
Conversely, an estimate can be made evaluating a negative test being truly negative. This is the negative 
predictive value (PVN) and is determined through this formula: PVN = (SP x (1-TP)) / ((SP x (1-TP))+((l-SE) 
x TP)). Using the same test statistics above for determining the PVP, the result would look like this: PVN = 
(0.98 x (1-0.10)) I ((0.98 x (1-0.10))+((1-0.45) x 0.10)). The PVN would equal 94.1 %, indicating that a 
negative test had a 94.1 % chance of being a true negative or a 5.9% chance of being a false negative.69• 17 
Table 3 demonstrates the positive and negative predictive values for various testing means, sensitivities 
and specificities.69• 17 The ELISA 25 test is calculated using a sensitivity of 25% and a specificity of 98%. The 
ELISA 60 has a sensitivity and specificity of 60% and 97%, while the culture is at 40% and 99 .9%, 
respectively. 
Table 3. Positive and Negative Predictive Values for Various Testing Means 
Estimated ELISA25 ELISA60 Fecal Culture 
Prevalence PVP PVN PVP PVN PVP PVN 
1% 15% 99% 16% 99% 99% 99% 
5% 48% 96% 51% 97% 100% 97% 
10% 67% 92% 69% 95% 100% 94% 
20% 82% 84% 83% 91% 100% 87% 
30% 88% 75% 90% 85% 100% 80% 
40% 92% 66% 93% 78% 100% 71% 
50% 95% 57% 95% 71% 100% 63% 
Likelihood Ratios 
Likelihood ratios are the true-positive rate divided by the false-positive rate. This can also be expressed 
as the test sensitivity divided by (1 - test specificity). This can be a useful statistic as it removes the influence 
of prevalence rate from the calculation ofrisk. It adds value to producer information by providing odds ratios 
vs. a pure positive/negative classification. According to manufacturer instructions, samples that are 0.1 optical 
density (OD) units above the test negative well should be considered positive. Table 4 is a likelihood table 
calculated for various OD readings for the serum ELISA test. 55 
Table 4. Likelihood Ratios 
Difference between ELISA 
result and negative control 
(OD units) 
0.0 
0.050 to 0.099 
0.100 to 0.149 
0.150 to 0.199 
0.200 to 0.249 
0.250 to 0.299 
0.300 to 0.349 
0.350 to 0.399 
0.400 to 0.449 
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For any particular ELISA OD reading a likelihood ratio can be determined. This is the equivalent of the 
number of times the result is more likely to be from a M paratuberculosis infected cow vs. a noninfected 
animal. For example, an animal with a reading of O .11 would be 29 times more likely to be infected with M 
paratuberculosis and would be 1.5 times as likely to be shedding the organism in its feces .55 These ratios 
would be useful tools in assisting producers in making culling choices. 
Treatment of Johne's disease 
Historically, treatment of clinical Johne' s disease has been limited to animals of very high genetic merit. 
M. para tuberculosis can be isolated from the accessory glands and semen of the bull, as well as the uterine tract 
of the cow. A cow that is heavily infected has a 20 - 40% chance of delivering a calf that is infected in-utero.5 
With this in mind treatment efforts have been pursued with the goal to preserve genetic lines through further 
embryo retrievals or semen collection. 19 
Prior to the decision to treat, several factors must be considered in consultation between the veterinary 
practitioner and the producer. The first of these factors center on satisfying the terms of the regulations 
codifying the Animal Drug Use Clarification Act of 1994 (AMDUCA) enacted by the Food and Drug 
Administration (FDA). This act allows the veterinary practitioner to make use of human pharmaceuticals only 
after the following considerations: Within the terms of a valid client/patient relationship a definitive diagnosis 
of Johne's must be made; determination must be made that no labeled food animal drug exists to treat the 
patient; a substantially extended withdrawal period must be determined for both milk and meat that is 
appropriate to the treatment choice; the animal must be clearly identified by both animal ID and through the use 
of treatment records; and appropriate measures must be taken to ensure that the extended withdrawal times are 
met and that no illegal residues enter the human food chain. 
Given the long-term, if not lifetime, therapy required and the class of chemotherapeutics that have to be 
administered, the treated animal will in reality never be in a position to move through the human food chain. 
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An additional consideration is the cost of human anti tuberculin and antilepretic drugs given at effective dosage 
levels and for a very long period of time. The final reality of treatment is that chemotherapy is not a definitive 
cure, rather it effects remission/palliation. 19 It is entirely possible that the removal of antibiotic therapy may 
result in the exacerbation and fatal reoccurrence of the disease symptoms. With this clearly in mind, these 
antibiotics could be considered for treatment purposes: isoniazid, rifampin, clofazirnine, dapsone, streptomycin, 
kanamycin, amikacin and ethambutol. 19 
In the face of concerns about antimicrobial resistance, research efforts have moved toward the 
identification of immune system modulators that may prove effective in heightening immune system responses 
to specific pathogens. Work by Kreeger at al. examined the effects of leukocyte lysates containing transfer 
factor on animals infected with chronic Johne's disease.70 Transfer factor is so named due to the transfer of 
delayed hypersensitivity to animals devoid of this response. It is theorized that the persistency of 
paratuberculosis (failure to clear) in cattle is due to the individual inadequacies of the cell-mediated immune 
system. Blood monocytes and monocyte-derived macrophages from noninfected cattle have been shown to be 
unable to effectively kill the organism, thus allowing intracellular proliferation. A deficient T cell response 
( e.g., decreased killer T cell and cytotoxic activity and interferon production) could explain why infected cattle 
cannot eliminate the organism. 
Treatment efforts in humans using transfer factor have been attempted in the areas of cancer 
immunotherapy, internal parasitism, lupus erythematosus, sarcoidosis, lepromatous leprosy, and intestinal 
cryptosporidiosis in patients with human immunodeficiency virus infections. Treatment results have been 
variable, but have shown some promise as indicated by an increase in IL-2 activity. At this point, transfer factor 
is a crude product and contains both suppresser and induction agents, thus explaining the wide range of 
applications listed above. Treatment of cattle chronically infected with M. paratuberculosis showed little effect 
and no increase in lymphocyte blastogenesis in this study, but more research effort is indicated by increased IL-
2 activity in the enrolled cattle. 70 
Regulatory Concerns 
Current regulations in the United States are a patchwork affair with rules governing Johne's disease 
varying from state to state. The federal regulations do not provide a much better model. The Code of Federal 
Regulations ( CFR) Parts 80 and 71 are the current governing statutes. 22 Part 80 directly concerns the interstate 
movement and identification of animals that are Johne's disease reactors by the Secretary of Agriculture. As 
this rule was "outdated, not enforced, and not supported by the livestock industry" a change was made to 
remove the designated "reactor" status.22 This in effect removed any restrictions on the interstate movement of 
Johne's positive cattle. The only potentially enforceable regulation is Part 71 which restricts the interstate 
movement of "diseased" animals. With the lack of federal guidelines it must be expected that the regulations 
between states would be highly variable and a patchwork effort at best. 
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A concern for the practicing veterinarian is the creation of health papers. Most will contain a general 
statement that the animal has been examined by a licensed, accredited veterinarian, and is not exhibiting any 
sign of contagious disease. In a case where the veterinarian has knowledge of Johne's disease within a herd, 
this may present some very real ethical concerns about the signing of a health paper, especially given the 
insidious nature of this disease. A legal brief published in the Journal of the American Veterinary Medical 
Association warned of the possibility of a judgment being rendered against a veterinarian that "fails to warn a 
seller or a buyer of the risk to other animals" when an interstate health paper is written. It may be prudent for 
the veterinarian writing the certificate to state that the signing veterinarian gives no guarantee that the animals 
listed are free of M. para tuberculosis infection. 22 
An attempt has recently been made to offer a solution to the patchwork nature of Johne ' s regulations in 
the United States. The United States Animal Health Association (USAHA) was created more than 100 years 
ago by the sanitary boards of Texas and Missouri to control Texas fever. The primary objective of this 
organization was to "prevent, control and eliminate livestock diseases that cost ranchers, farmers, and 
consumers approximately $1 billion per year." From this mission statement a National Johne 's Working Group 
(NJWG) was formed in 1997 to make recommendations to facilitate control and eventual eradication of 
paratuberculosis. 71 
A program was designed that would be voluntary in participation, but provide the framework for 
individual herd owners to be certified by their state of origin as having completed various levels of the program. 
The assignment of these levels would provide a rough guideline to potential buyers of the risk of purchasing a 
Johne ' s infected animal from the participant. The program consists of five levels with the first, undeclared level 
being the untested herd. From that point a producer can ascend through the four program levels at his/her own 
pace choosing to remain at a level with an annual repeat of testing procedure, or deciding to ascend to the next 
level with the completion of the testing requirements unique to that stage. 83 
The initial two stages of testing focus on the ELISA test and cattle that are second lactation or greater. 
The third stage mandates a fecal culture of all individuals first lactation or greater. The fourth and final test 
returns to the ELISA method and sampling a statistical population of all second lactation and greater cows. 
With the completion of each test a percentage value is assigned estimating the probability of the herd being free 
of Johne ' s. Unknown herd status is assigned a 70% chance of being free, while level 1 is 85%, level 2 is 95%, 
level 3 is 98% and level 4 is 99%. While serial testing increases the likelihood that a herd may be free of 
Johne ' s this program wili never declare a herd 100% free due to the insidious nature of the organism.83 
Confidentiality of testing has been a major issue in the adoption of this framework by individual states. 
Producers desire that the results remain entirely confidential, while most state laws demand open access to 
testing records. It is hoped that implementation of this framework will prove a desirable advertising feature and 
increase herd value for those that successfully complete individual level testing. This would be an incentive for 
producers to forge ahead with herd clean-up efforts vs. the current attitude of not testing or hiding the results. 
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For further details on this program the reader is directed to the USAHA website 
http://www.usaha.org/reports98/r98js2.html for the full text and description of this program.83 
Crohn's disease - Is M. paratuberculosis a Zoonotic Agent? 
Crohn's disease (Crohn's colitis, Crohn 's ileitis or regional ileitis) is a chronic granulomatous ileocolitis 
of humans whose etiological agent is unknown. 72 •73 The trans-mural granulomatous inflammatory response is 
considered diagnostic for the presence of Crohn's disease and has great similarity to the histopathology of cattle 
with Johne ' s disease. 15 The symptomology ofCrohn's includes chronic weight loss, abdominal pain, diarrhea 
or constipation, vomiting and lethargy. It generally strikes during young adulthood (teens to twenties) and has a 
slight predisposition towards females vs . males. Treatment efforts focus on the surgical resection of the 
affected bowel, with 70 - 80% of those suffering this condition undergoing surgery. Further control efforts are 
symptomatic and centered on the use of steroidal anti-inflammatories, immunosuppressives and antidiarrheal 
agents. 
Current investigative efforts have centered in the areas of allergic reactions, autoimmune dysfunction and 
infectious agents. None of these investigations has been able to identify the etiological agent. Epidemiological 
evidence to date supports a multi-factorial etiology with both environmental and inherited factors involved.73 
The local intestinal response to the unknown stimulus has been characterized as a hyper-responsiveness of the 
internal immune system to a persistent environmental stimulus. 72 This could be an over exuberant response to 
an exogenous source (M paratuberculosis?) or an attack on an endogenous source such as the intestinal tissue 
itself. The common thread in both possibilities is that symptoms suggest a defect in the "down regulation" of 
the intestinal immune response. 
Previous efforts to characterize this disorder centered on the description of regional ileitis . As work 
progressed it was found that regional ileitis could be split into two separate entities known as Crohn's disease 
and ulcerative colitis. These are now known as inflammatory bowel disease (IBD). The significance of these 
two entities is that ulcerative colitis is frequently used as a negative control in the study of Crohn's. 
Experimental work looking at the presence of M paratuberculosis focuses on the isolation of this organism 
from both conditions. 72 
M. paratuberculosis was first isolated in 1984 from 3 patients suffering from Crohn's disease and not 
from control patients. Primary isolations of the bacilli occurred in the spheroblast, or cell wall deficient form 72 • 
True confirmation of M. paratuberculosis occurred with the transformation of the organism back to a bacillus. 
This occurred in approximately 25% of the isolations. Subsequent work showed that the isolated strains were 
genetically identical to the strains of M. paratuberculosis originating from cattle. These strains were able to 
cause disease in infant goats when orally inoculated 15• Other labs have reported the isolation of M. 
paratuberculosis from human patients but only in a small percentage of cases. Summarization of cultural 
retrieval has demonstrated isolation of M. paratuberculosis in 7.5% of the Crohn's tissues and 0.3% of the 
controls. 72 
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Due to the difficulty of organism recovery, the focus has shifted to the DNA probe method and 
examination for IS900. Studies examining surgical resection tissues of Crohn's and control patients have 
demonstrated isolations on the average of30% in Crohn's patients compared to isolations of0.8% in control 
patients. Summarization of studies has shown organism recovery rates ranging from 13% to 100% in Crohn's 
patients, while control isolations range from 0% to 88%. 73 In nearly all studies, isolations in the Crohn's 
patients were higher than the controls, but the presence of this organism in control tissues is consistent with it 
being prevalent in the normal intestine.73 Work by Francois et al. 74 compared human and animal isolations of 
M. paratuberculosis at the DNA level, both by analysis of restriction fragment length polymorphism (RFLPP) 
in and around the insertion sequence IS900 and by the arbitrarily primed polymerase chain reaction (AP-PCR). 
Results favor a common clone origin for the 4 strains isolated from Crohn's disease and for 8 of the 11 strains 
isolated from cattle and sheep with Johne ' s disease. 
The question has become, is M. paratuberculosis a surface opportunist of disrupted tissues or is it truly 
infecting the tissues themselves? Work on acid fast staining and immunohistochemistry of resected tissues has 
proved unrewarding. DNA:DNA hybridization performed to detect the DNA ofmycobacteria within tissues 
indicated 53% of the Crohn' s patients, 33% of the ulcerative colitis cases, and 17% ofnon-IBD cases 
demonstrated evidence of mycobacterial DNA. This tends to point towards opportunistic colonization of the 
disrupted mucosa in both Crohn's and IBD patients.72' 73 In addition to the DNA probe studies mentioned 
above, further work has focused on the M. avium insertion sequence IS902. Results indicated an across-the-
board level of isolation approaching 14.8% for all three types of tissue samples, Crohn' s, ulcerative colitis and 
non-IBD cases. This would reflect the environmental nature of all species of mycobacteria, which can be 
cultured or isolated in 30% to 50% of all soil, water and even air samples. 72 Detection doesn't confirm an 
etiological agent. At this time it is not known whether the association is causal or coincidental. 15 
As Crohn's disease is well described as a hyper-responsive immunological event, an immunological 
response to M. paratuberculosis should be evident. 72• 73 Demonstration of this event would point toward an 
etiological relationship. Summarization of work to date indicates half the studies show a response, while half 
do not. Thus the work is inconclusive to demonstrate a response to either M. paratuberculosis or any other 
mycobacteriurn. 
Johne's disease affects cattle and it would be expected that if a link existed between M. paratuberculosis 
infection and Crohn's, the incidence rate ofCrohn's would be higher among rural communities, farm and 
animal health care workers. No such increase in incidence rate has been identified; conversely an increased 
Crohn's rate has been demonstrated in urban areas.72 This may be due to over-representation of urban 
populations in these studies, but no clear link in the above mentioned rural populations has been demonstrated. 
Work has also focused on identification of a reservoir of infection with milk as the source. Studies have 
been performed using the DNA probe detecting IS900 (Millar et al.). 72 The insertion sequence was found in 
approximately 7% of the samples (18 of254) from cartons of milk purchased from retail outlets in central and 
southern England. The high levels of isolations (25%) appeared during the winter months, while no positive 
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results were obtained through the months of April through July. Identification using IS900 cannot differentiate 
between living, dead or destroyed bacilli. As a follow-up, all samples were cultured and 9 samples yielded 
long-term positive liquid cultures after 13 to 40 months of incubation. 
Grant et al. and Hermon-Taylor found that M. paratuberculosis suspended in raw milk is more heat 
resistant than M bovis, which is one of the reference organisms for current pasteurization heat and time 
requirements. If in high enough numbers, M. para tuberculosis could survive high temperature, short time 
pasteurization. Hermon-Taylor determined that the rate of cooling following heating and strain differences also 
affected survival. 15 Recent work by US Department of Agriculture (USDA-Agricultural Research Station) 
indicates that pasteurization is adequate to inactivate M. paratuberculosis in milk, but it will not remove the 
organism. 10 In this study the authors attempted to culturally isolate M. paratuberculosis from the IS900 positive 
samples; none were successful. 
In examination of food-borne contamination two questions must be answered. The first is what is the 
thermal death curve of M. paratuberculosis and the decimal reduction time. The second is what is the expected 
number and possible range of M. paratuberculosis per milliliter of milk. The death rate of this organism can be 
reliably predicted, but if contamination levels greatly exceed the reference bacilli can survive. Determination of 
contamination levels is very difficult, and when factoring in the additional consideration of meat and cheese 
contamination this is a question that will remain open for some time. 15 
If M. paratuberculosis is a causal agent of Crohn's disease in humans it can be asked what type of 
transmission is occurring. The potential exists and can 't be discounted for transmission among humans. M. 
paratuberculosis is not a free-living organism in the environment, and it is plausible that the primary reservoir 
(animals) could serve as a transmission source to humans. During clinical infection ruminants shed the 
organism through their feces and milk. Additionally, blood-borne dissemination occurs with the subsequent 
infection of several organ tissues such as lymph nodes, gastrointestinal tract, liver, kidney, spleen, uterus, 
mammary gland and epididymis. This potentially opens the door for contamination of human food through 
both pre-harvest and post-harvest contamination. Further work is indicated with respect to thermal inactivation 
to adequately judge the risk of food-borne transmission to the human population. 15 
As mycobacterial species may be treated with chemotherapeutics it would be expected that remission of 
Crohn's disease would occur with the application of these products. 19 Spontaneous remission of Crohn's can 
occur in approximately 20% of cases. Additionally, placebo effects can occur in 30% to 40% of patients with 
short-term therapy. This is a major complicating factor in the assessment of successful treatment. Beyond that 
M. paratuberculosis and M. avium appear to be very resistant to treatment when compared to M. tuberculosis. 72 
Furthermore, little is known about the efficacy of these drugs on the spheroblast phase of these bacteria. 
Recently multi-drug resistant variants of M. tuberculosis have been demonstrated. Treatment failures are well 
described if the proper antimicrobial regimes are not employed. If treatment efforts for M. para tuberculosis 
resemble the multi-drug resistant variants it may be extremely difficult to treat. Therefore, it is very difficult to 
draw any conclusions about M. paratuberculosis as an etiological agent of Crohn' s with response to therapy. 72 
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At this time the possible relationship between M. paratubercu/osis infection and human Crohn's disease 
can' t be ignored, but its etiological relationship has not been proven. Food animal veterinarians are intimately 
involved with food safety, so this must remain an item of concern to the profession. Additional work is needed 
to determine that pasteurization will consistently kill this organism in the food supply at all shedding levels . 
The following is a summary of the components both pro and con towards the etiological role of M 
paratuberculosis and Crohn' s:72 
Information Supporting 
1. Pathology similarities 
2. Cultivation of M. paratuberculosis from some patients 
3. Ability of human isolates to cause disease in experimental animals 
4. Detection ofIS900 in some human patients with Crohn 's 
Information Against 
1. Lack of pathological hallmark (acid-fast bacilli, as can be demonstrated in infected animals) 
2. Low cultivation success 
3. Variability of PCR data 
4. Detection ofIS900 in control patients 
5. Suggestion of an environmental opportunistic role 
Literature Review Conclusions 
The history of Johne' s disease is filled with the frustration of dealing with a disease syndrome that 
defines the term insidious. The long-term growth pattern of Mycobacterium paratubercu/osis defies research 
efforts to deal with it in an expedient manner. These same growth patterns lull producers into a false sense of 
security when they believe they are dealing with Johne's by culling clinical cases. Research has also been 
hampered by the paradoxical immune system response of the disease. Thus, the ability to define a subject 
bovine as truly negative for testing purposes becomes a "best guess" effort. 12 
Research is beginning to make some inroads into Johne 's disease through development chests with 
increasing amounts of sensitivity while maintaining high levels of specificity. This is occurring in all fields of 
testing including culture, PCR identification, antibody detection, and y-IFN determinations. With increasing 
sensitivity and specificity the question will shift from the inadequacies of the testing procedures to how 
committed the producer is to removing identified M paratuberculosis infected animals from the farm. This 
may become an even more pressing issue if a definitive link with human Crohn' s disease is established. 
In the following study the authors seek to add to the body of knowledge concerning increasing the 
sensitivity and specificity of the y-IFN test. A cell-free sonicate of M. paratuberculosis strain 19698 was 
administered as a pre-treatment to a group of cattle identified as positive, suspect and negative for the 
production ofy-IFN. The enrolled animals were serially monitored for any increased or enhanced levels ofy-
IFN as a result of the cell-free sonicate pre-treatment. 
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COMPARISONS OF THE MILK ELISA, SERUM ELISA, GAMMA-INTERFERON 
AND FECAL CULTURE TESTS FOR THE DETECTION OF JOHNE'S DISEASE 
IN AN IOWA (UNITED STATES) HERD 
A paper submitted to the American Journal of Veterinary Research 
M.A. Kirkpatrick1, K. W. Kersting 1, J. R. Stabel2, and D. J. Nordman3 
INTRODUCTION 
Mycobacterium avium subsp. paratuberculosis is the causative agent of Johne ' s disease. 
Paratuberculosis is a chronic mycobacterial infection of the lower small intestine and associated lymph nodes 
affecting many ruminants including cattle, sheep, goats, llama, deer and bison.1'3'4 It is primarily a wasting 
disease, but is also evidenced by profuse, watery, untreatable diarrhea in cattle. Bovine oral infection generally 
occurs during the first 6 - 12 months of life with manifestation of the clinical disease 2 - 5 years later. 
Paratuberculosis is an economically devastating disease of ruminants. Recent estimates indicate the loss 
to dairy producers includes 640 million kg of milk, additional culling of 11 ,000 cows, and nearly 20,000 cow 
deaths (based on a total population estimate of9,458,000 dairy cows). The total amount ofrevenue lost is 
approximately $222 million. 7•8 
Current testing methods have frequently been criticized by the cattle industry as being too insensitive to 
be of any value. The intracellular location and slow, progressive nature of the disease (4-day generation time of 
M. para tuberculosis) results in delayed or undetectable immune responses. 11 ' 17 Research has been stymied due 
to the inability to truly declare an animal non-infected. Fecal and tissue culture have been considered the 
"gold" standard of isolation, but 12 - 16 weeks growth requirements have taken a toll on research efforts and 
producer motivation. 11 
Multiple testing methods are available to the practitioner for determining the presence of Johne's disease. 
These include: four means of organism detection and/or isolation, four means of antibody assay, and two assays 
for the presence of a cell-mediated response in the form of gamma-interferon (y-IFN) determinations, and a 
DTH skin reaction.21 The available testing procedures are most sensitive in detecting Johne ' s in animals in 
Clinical Disease or Advanced Clinical Disease. 44 
Patterns of measurable immune response vary from animal to animal, with the early stages of infection 
being immunologically indicated by cell-mediated reactions from active proliferation and differentiation ofT 
cells. As the onset of clinical signs approaches, the measurable systemic reaction shifts to a predominantly 
humoral (antibody) response and organism shedding. The shift to a humoral response comes at the expense of 
1Iowa State University, Veterinary Diagnostic and Production Animal Medicine, Ames, Iowa 
2USDA/ARS/National Animal Disease Center, Ames, Iowa 
3 Iowa State University, Statistical Department 
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the cell-mediated phase. In the final stages of disease the animal may lapse into a period of anergy (no immune 
response) as both cellular and humoral responses diminish. 12 
Multiple testing means allow identification of the differing immunological signalments of Johne's 
disease.57 This can be considered an advantage as these responses are from differing populations within Johne's 
disease progression. With this in mind the ELISA test can be used in a parallel manner with fecal culture to 
increase detection sensitivity. This sensitivity increase would come with the premise that a positive on either or 
both testing means would be considered a positive designation. Collins et al. suggest combination sensitivities 
may approach 69%. 55 
The objectives in this trial were to compare and contrast multiple means of testing in an Iowa herd, to 
examine the possibility of increased sensitivity with multiple tests, and to characterize this population for 
selective enrollment of individuals for further serial testing utilizing the gamma-interferon (y-IFN) assay. 
MATERIALS AND METHODS 
Classification Trial. Cattle used in the study were obtained from the Ames Dairy facility at Iowa State 
University,. This teaching herd represents the six major dairy breeds and consists of 102 Holsteins, 26 Jerseys, 
8 Guernseys, 17 Ayrshires, 17 Brown Swiss, and 9 Milking Shorthorns. While no clinical cases of Johne's 
disease were observed in this herd, initial fecal sampling I year previous indicated a true prevalence rate 
approaching 10 to 12%. 
The study focused on testing procedures with the exception of the y-IFN assay, that are readily available 
to the US veterinary practitioner. Samples from the herd were submitted during a IO-day period utilizing milk 
ELISA (MELISA) (Dairy Lab Services; Dubuque, IA), serum ELISA (SELISA) (IDEXX Laboratories; Inc.; 
Westbrook, ME), y-IFN assay (CSL Limited; Parkville, Victoria, Australia) and fecal culture (National Animal 
Disease Center; Ames Iowa). Sampling consisted of obtaining 2 oz of fluid milk for MELISA assay at the 
regular dairy records processing center (DRPC) monthly check. Five days later the cattle were restrained and 
60 ml of blood was obtained for partitioning between a 10-ml sodium heparin tube and three 15-ml serum 
separator tubes. The heparinized whole blood sample was delivered to the laboratory within 6 hours for y-lFN 
assay. Serum from the separator tubes was used to obtain a serum sample for ELISA determination, with the 
balance being subdivided for serum banking purposes. A fecal sample was also submitted for M. 
paratuberculosis culture. 
Milk ELISA. 85 Milk was harvested into a 2 oz snap-cap vial containing 0.5 ml of Bronolab-W® (2,-
Bromo-2, Nitro Propane-L; D&F Control Systems; San Ramon, Ca.) by the DRPC technician performing the 
herd test. The sample was placed in a Styrofoam shipping container, and shipped unrefrigerated to Dairy Lab 
Services, Inc. Sample requirements include the following : 
1. Samples must be run in less than 4 days from the sampling date. 
2. Cows must be at least 10 days into lactation to avoid false positives. 
3. Samples should not be refrigerated. 
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The following are test reagents used in the processing of the milk samples: Phosphate Buffered Saline Tween 
80 Gelatin solution (PBSTG) is 1,250 ml of a 0.20 % solution of Sodium dihydrogenphosphate monohydrate 
(NaH2PO4; Sigma; St. Louis MO), with 21 drops Tween 80 (T80 - Polyoxyethylene-sorbitan mono-oleate; 
Sigma; St. Louis MO), 10.60 g NaCl, 15.45 g Sodium hydrogen phosphate (Na2HPO4; Sigma; St. Louis MO) 
and 1.25 g EIA grade reagent Gelatin (Biorad; Hercules, CA). The PBSTG must be buffered to pH 7.6 using 
NaOH. Tween saline solution consists of 500 ml of0.85% NaCl solution and 9 drops of Tween 80 
(Polyoxyethylene-sorbitan mono-oleate; Sigma; St. Louis MO). 
Test controls were prepared by adding 25 µl of M. paratuberculosis positive control (Allied Monitor; 
Fayette, MO) to 2 ml of PBSTG and by adding 10-15 µl of M. paratuberculosis negative control (Allied 
Monitor; Fayette, MO) to a second 2-ml of PBSTG. Immulon® 96-well plates (Dynex Technologies; Chantilly, 
VA) were sensitized by adding 100 µ1 to each well of a solution of 20 ml, 0.6% Na2CO3 (Sigma, St. Louis, MO) 
and 144 µl of Paratuberculosis Protoplasmic Antigen (PPA) (Allied Monitor; Fayette, MO). The plate was 
placed in a re-usable ziplock bag and refrigerated at 6 C for 18-48 hr (plates must be used within 48 hr 
following sensitization). Milk samples were warmed to 40 C and once cool were rolled to remove the cream 
line. A culture tube (12x75 mm, Kimball, Raleigh NC) was filled approximately one-third full with the test 
sample milk. The sensitized plate was then "slung" and filled with Tween saline. The plate was immediately 
slung and refilled with Tween saline, allowed to stand 2 min and the procedure repeated, followed by another 
slinging after an additional 2 min period. Slinging consists of: 
1. Dumping plate contents 3 times. 
2. Tapping plate on towel 3 times. 
3. Shaking plate in the air 3 times. 
The milk sample was vortexed and 100 µl was pipetted into each of 3 consecutive wells. The filled plate 
was incubated at 12-15 C for 2 hr. Immunoglobulin G Conjugate (IgG) (Allied Monitor; Fayette, MO) is 
thawed 5 min prior to the end of incubation to create an IgG PBSTG solution. Actual product mixing rates vary 
with the manufacturers IgG lot number. Following incubation the plates were slung, washed with PBSTG 4 
times and 100 µl oflgG was added to each well. The plates were re-incubated at 12-15 C for an additional 90 
min. Following incubation, the plates were slung and rinsed 3 times with PBSTG, followed by the addition of 
100 µl of substrate solution. The substrate solution consisted of 20 ml of pH 4.0, 1 % citrate buffer, with 100 µl 
of2.3% Diammonium salt solution (ABTS; Sigma; St. Louis, MO) and 4.4 ml of hydrogen peroxide solution 
(H2O2). The H2O2 solution consisted of 3.0 ml distilled water and 1.4 ml H2O2 (30 wt% H2O2 solution in water 
34.02 fw; Aldridge; Milwaukee, WI). Using an optical density plate reader set at A4oswn (Model # ELX800; 
Biotech Instruments; Winooski, VT) the plate was read until the threshold value for the positive control 
exceeded 240. The positive control value was recorded and the balance of the sample wells were read for 
optical densities. 
The results were interpreted by averaging the 3 results of positive control (P). Outlying values were 
discarded prior to averaging. There were 2 sets of positive control wells per plate. The 3 results from each 
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T bl 1 MELISA SIP G d E a e : 
' 
ra e, xposure an ecommen a ions. dR d f 85 
Numerical SIP Assigned Antibody Level & Recommendations 
Range Value Probable Exposure 
Individual cow samples 
1.0-2.0 A Low Continue routine Mille ELISA testing 
2.1 - 3.5 B Moderate Retest by Serum ELISA/ Mille ELISA in 6 mo. 
3.6-5.0 C High Retest by Serum ELISA 
5.1 - 10.0 D Very High Retest by Serum ELISA: Cull as advised by 
veterinarian 
Bulk tank samples 
1.0- 1.2 A Low Routine annual Mille ELISA testing of bulle tank 
or individual cows 
1.3 -2.0 B Moderate Test individual cows by Mille ELISA or Serum 
ELISA: consult veterinarian 
2.1-4.5 C High Test individual cows by Serum ELISA: consult 
with veterinarian 
sample (S) were averaged following outlier discard. A Sample/Positive (SIP) ratio was calculated. Table I 
describes the recommendations associated with the SIP ratios. 
y-IFN Assay. All blood samples for y-IFN assay were maintained and transported at room temperature 
(20 C to 30 C) and processed within 12 hr of collection. The whole heparinized blood was dispensed in 6 - 1.0-
ml aliquots in 24-well tissue culture plates (Falcon; Becton-Dickinson; Franklin Lakes NJ). Blood samples 
were cultured alone, nonstimulated (NS), or with concanavalin A (ConA) and pokeweed rnitogen (PWM) at a 
concentration of IO µg/ml to act as positive controls within the assay to evaluate cell function and test for 
anergic responses. The remaining 3 samples were plated with avium purified protein derivative (AvPPD), bovis 
purified protein derivative (BoPPD) or a whole cell sonicate of M. paratuberculosis (19698 MpS). 
Whole blood cultures were incubated for 18 hr at 39 Cina humidified atmosphere of 5% CO2• Plates 
were centrifuged at 500 x g for 15 min and plasma was harvested from each well. Plasma samples were frozen 
at -20 C until analyzed for y-IFN concentration by ELISA using a commercial kit. Plasma samples were 
incubated in 96-well plates precoated with an anti-bovine y-IFN antibody for I hr at room temperature. After 
washing with phosphate buffered saline (PBS), plates were incubated at room temperature for 30 min with anti-
bovine y-IFN-horseradish peroxidase conjugate. Plates were washed again and incubated with substrate 
solution (tetramethylbenzidine, TMB) for 30 min at room temperature. Dilute hydrochloric acid was added to 
each well as a stop solution and plates were read on a MR7000 rnicroplate reader at A650nm. A sample was 
considered positive if the absorbance of the stimulated sample (19698 MpS) was 0.100 absorbency (abs) units 
greater than the absorbance achieved for the nonstimulated control well for that animal. 20 
19698 MpS Production. Cell-free soluble protein 19698 MpS was prepared by sonication of I-ml 
volumes of M. paratuberculosis (l x 109/ml) in phosphate buffered saline (PBS) at 25 W for 25 min, followed 
by centrifugation at 1,400 x g for 5 min to pellet the cellular debris. The cell-free supernatant was removed and 
a protein concentrate was determined. Final concentration of each PPD or MpS in culture was IO µg/ml.20 
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Absorbed ELISA. Serum was harvested from the blood samples and presented to the Iowa State 
University Veterinary Diagnostic Laboratory for antibody determination using a commercial ELISA kit. The 
samples were processed according to manufacturer's instructions. 59 Samples were placed in diluent containing 
M. phlei to remove cross-reacting antibodies and dispensed into 96-well plates coated with M. paratuberculosis 
antigen. Samples were incubated for 30 min at room temperature, plates were washed 4 times and horseradish 
peroxidase-conjugate was added to each well. After incubation plates were washed again and TMB substrate 
was added. Plates were incubated for another 15 min at room temperature and a stop solution (0.125% 
hydrofluoric acid) was added to each well. Plates were read at A6sonm-
Fecal and Tissue Culture. Fecal samples (1 gram) were added to 35 ml sterile deionized water, shaken, 
and allowed to settle at room temperature for 30 min. After settling, the entire supernatant fraction (25-30 ml) 
was removed and placed in a clean 50 ml tube. Samples were then centrifuged at 1,700 rpm for 20 min, the 
supernatant was decanted, and a pellet was resuspended in 30 ml 0.75% final concentration 
hexadecylpyridinium chloride (HPC) and half strength brain heart infusion broth (BHI). After overnight 
decontamination at 37 C, samples were centrifuged at 1,700 rpm for 20 min. After supernatants were removed, 
pellets were resuspended in 1 ml antibiotic solution (100 µg /ml naladixic acid, 100 µg/ml vancomycin, 50 
µg/ml amphotericin B) and incubated overnight at 37 C. Sample suspensions (0.2 ml) were pipetted onto 4 
tubes ofHerrold's egg yolk media (HEYM) containing naladixic acid (50 µg/rnl) and vancomycin (50 µg/ml) 
and incubated. Inoculated tubes were incubated in a horizontal position with loose caps for 1 wk at 37 C to 
permit evaporation of residual moisture from the surface of the medium. Caps were then tightened, tubes 
returned to an upright position, and incubation of samples continued for a total of 12 wk. Tubes were examined 
every 4 wk and colonies were enumerated using a dissecting microscope at 25X magnification. 20•45 
Statistics. Johne's test results were gathered on each individual and placed into an Excel spreadsheet 
(Microsoft Corporation, Redmond WA), along with individual cow production data from PC-Dart (Raleigh 
Dairy Records Processing Center, Raleigh NC). The spreadsheet was sorted and ranked on each individual test 
parameter. Individuals with no test results were removed from consideration and a percentage positive for each 
individual test was then calculated. 
For comparison of 2 test procedures all individuals with 1 or more missing tests were removed from 
consideration. Animals were identified as negative to both tests, positive to 1 test and negative to the other, or 
positive for both tests . Percentages were calculated for each of the four possibilities, and the data was plotted 
on an XY graph. The kappa statistic was calculated as per instructions. 82 Comparison of ages at positive test 
was performed using pairwise t-tests (The SAS System; Software Release 6.12; SAS Institute; Cary NC). 
RESULTS 
The MELISA test returned the greatest number oftest positive individuals at 12.96% of the herd (21 of 
162). All positives were assigned a "B" grade. No "C" or "D" grade positives were found (Table 1.). The 
SELISA followed with 7.41 % test positive (14 of 189). These individuals showed a SIP ratio of~ 0.250. The 
y-IFN assay found 4.40% (8 of 182) had an optical density of0.100 absolute units above the non-stimulated 
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standard. The fecal culture yielded 0% positive. For the entire herd the percentage of individuals negative to 
all testing was 74.19% (115 of 155). 
All results were reported numerically as either SIP ratios or absolute optical densities. Average values 
were determined for test positive and negative individuals as well as an overall test average value for each 
testing method. These values shown in Table 2. Individual cow data was obtained using PC-Dart records 
(Dairy Records Processing Center, Raleigh, NC). Average values were determined for age in months for both 
test positive and negative cattle. The SELISA test (P > JTJ = 0.0192) had a significantly lower age at test 
positive than the MELISA and y-IFN. Within the SELISA assay there was a significant difference between test 
negative and positive (P > JTJ = 0.0296). 
Table 2: Test Results Mean Values 
Mean Positive Value 
Mean Negative Value 
Mean Test Value 
Standard Deviation of Positive Values 
Mean Age (mon.) Positive Animals 
Mean Age (mon.) Negative Animals 

























The results of each of the three diagnostic tests were cross-examined using an XY scatter plot to allow 
visualization oftest agreement. The comparison of the MELISA vs. the SELISA test (Figure 1) yielded 125 
individuals negative by both tests, 20 positive MELISA, 14 positive SELISA, and 0 individuals both tests 
agreed were positive. Test agreement was indicated by a kappa value of -0.116. Comparison of the y-IFN test 
vs. MELISA (Figure 2) yielded 126 individuals negative by both tests, 20 positive MELISA, 8 positive y-IFN, 
and 1 individual both tests agreed was positive. The kappa value for test agreement was 0.0005. Comparison of 
the y-IFN test vs. SELISA (Figure 3) yielded 159 individuals negative by both tests, 14 positive SELISA, 8 
positive y-IFN, and 1 individual both tests agreed was positive. The kappa value for test agreement was 0.0287. 
Values for kappa< 0.40 should be considered an indicator of poor agreement. 
DISCUSSION 
The MELISA test has recently been offered in Iowa by Iowa Dairy Lab Services Inc., for use in 
determining potential herd prevalence rates and individual determinations of Johne's disease.85 This method 
offers convenient sample collection compared to serum and can be obtained through routine milking 
procedures, thus limiting stress to cattle.61 The majority ofigG in milk originates from serum, although some 
local production occurs in the mammary gland itself. Thus the concentration of IgG in milk is proportionate to 
serum IgG.61 Milk could represent an ideal sample to detect the presence of M paratuberculosis antibody and 
the ELISA test can be adapted to process this sample medium. 
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Our study indicated the MELISA determined the highest percentage oftest positive animals at 12.96%. 
While this high rate of sensitivity looks encouraging, comparison with the results of the regulatory standard 
SELISA test casts some doubt. When compared using an XY plot (Figure 1) no common individuals were 
identified as test positive by both tests. Analysis of the proportions in each quadrant with the kappa statistic at -
0.116 indicated a very low percentage of agreement between the two testing means. The amount of agreement 
present could simply be due to chance. 
Other reports of MELISA results have not been encouraging. Hardin and Thome demonstrated that the 
ELISA test procedure for milk did not agree with results from serum ELISA determinations (kappa= 0.076).61 
Additionally, there was little agreement between the two tests in the determination of herd test prevalence rate 
or test positive percentage (R2 - 0.1077). Due to these discrepancies, and use of the SELISA as a regulatory 
standard, individual culling decisions or herd test prevalence rates determinations should not be made using the 
MELISA. 
Factors affecting the performance of the MELISA related to milk samples have not yet been identified. 
Hardin and Thome raised the issues of milk quality and quantity possibly impacting the agreement between the 
serum and milk ELISA tests. 61 As can be seen from the MELISA materials and methods, cows less than 10 
days fresh should not be checked due to the risk of false positives. Perhaps high somatic cell counts or the 
presence of clinical mastitis may adversely affect the outcome of the test. 
An additional factor is the sensitivity and specificity of the MELISA test. Sweeney et al. used a 
MELISA containing lipoarabinomannan (LAM) antigen. 62 Their work determined a specificity of 87% ± 8.1 % 
when the sensitivity cutoff was set at 50%. When the cutoff was raised to 60% the specificity dropped to 83% ± 
9 .1 %. The predictive value of a positive test using these values for sensitivity and specificity offers only a 29% 
chance that a positive test is correct. This value is too low to be considered useful for culling purposes. 
Evaluation of the data for mean values at positive test indicated that the SELISA had a significantly 
lower age at positive test (P > JTI = 0.0192) than did the MELISA or y-IFN. There was also a significant 
difference within the SELISA assay between test negative and positive status (P > !Tl = 0.0296). Conversely, 
there was no significant difference in the mean age of negative animals between the three testing methods. This 
raises potentially serious questions. Patterns of measurable response will vary from animal to animal, but active 
proliferation and differentiation of T cells is generally the first measurable immune system response through 
DTH reactions or assay of y-IFN.12 It would be expected that the y-IFN assay would have the lowest mean 
positive age vs. the antibody determinations. Furthermore, as the majority of IgG in milk originates from serum 
there should be little difference between the mean ages of the MELISA and SELISA methods.61 The results of 
the MELISA test can be criticized for the lack of agreement with the regulatory standard, but the results of the 
SELISA in this herd could be questioned for the presence of false positives due to the significantly lower mean 
age at positive test. 
Testing results can have great impact on examination and implementation of management practices. 
Examination of the SELISA positive results indicated a preponderance of test positive individuals as first 
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lactation cows. If this is correct, it would call into question the young calf management program in place at this 
herd. The Iowa State University Ames Dairy Herd has made an effort to control the spread of Bovine Leukosis 
Virus (BL V) within the herd, including serum BL V AGID testing of all lactating females. Any individual with 
a positive titer was considered contaminated and their colostrum was discarded to prevent transmission. 
Colostrum from negative cows was banked, frozen and retrieved for use when a BL V positive dam calved. At 
the time of implementation of this practice no Johne ' s disease determinations had been carried out due to lack 
of clinical cases. It is conceivable that a BLV negative, Johne ' s positive cow may have colostrum present in the 
bank that could infect calves coming in contact with it. This could represent a major Johne 's biosecurity 
breach. 
The fecal samples submitted failed to yield any culture positive individuals . No clinical cases of Johne's 
disease have been observed in this herd, but initial fecal culturing I year previous indicated a true prevalence 
rate approaching 10 to 12%. Fecal shedding of M. paratuberculosis can be an intermittent event, and in a 
stable, well-managed herd stress levels may be low enough to not greatly advance organism dissemination and 
subsequent shedding. Conversely, the lack of any fecal positives may call into question the results of the 
MELISA and SELISA as potentially having too many false positives. The combination of a significantly lower 
mean age of SELISA test positive individuals and no fecal culture positives would lend further credence to the 
false positive issue. 
A recent development in Johne's disease testing has been the introduction of the y-IFN enzyme-linked 
immunoassay (EIA). 12'63'65 This test of the cell-mediated immune system has the advantages of being rapid, 
numerically quantifiable, and not affecting the outcome of further testing through the injection of a PPD. By 
testing an earlier phase response this procedure holds promise of detecting earlier infections of M. 
paratuberculosis, identifying infected individuals prior to or during, early shedding and potentially allowing 
detection in younger cattle. 12 This study indicated a 4.40% positive rate, with a mean age of detection at 48.25 
months. As this is an earlier phase test, one would expect it to verify the age results seen using the SELISA and 
further identify positive individuals among the younger herd members. 12 The y-IFN assay did not verify the 
results of the SELISA. 
Cross-examinations of y-IFN results were conducted against the SELISA (Figure 2) and MELISA 
(Figure 3). Both antibody tests had similar responses with only I individual showing a positive agreement 
between the two types of testing procedures (antibody vs . interferon). Kappa statistics again indicated poor 
agreement between the tests with values of 0.0287 and 0.0005 respectively for the SELISA vs. y-IFN and 
MELISA vs. y-IFN. These kappa values would indicate poor agreement between the y-IFN assay and antibody 
determinations. In this case the lack of agreement would be expected. As seen in the kappa values, the 
difference between the two testing means indicates that two entirely different populations are being selected. 
Identification of separate populations would "widen the area of capture" and could result in increased sensitivity 
when used in a parallel manner. The MELISA and SELISA assays don't detect differing populations and as a 
result no increase in sensitivity should be expected with parallel testing using these two diagnostic modalities. 
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Additional evidence that the antibody ELISA and y-IFN detect differing populations is indicated by the 
physiology of the immune system. CD4+ type-IT-helper cells (TH 1) produce cytokines primarily consisting of 
interleukin-2 (IL-2) and gamma interferon (y-IFN) and mediate macrophage activation, delayed-type 
hypersensitivity (DTH) and are thus associated with cell-mediated immunity (CMI). CD4+ type-2 T-helper 
cells (T H2) produce large amounts of IL-4, IL-5, IL-6, and IL-10 and mediate antibody production (IgG 1 and 
IgE) and eosinophilia. 12• 36 Production of IL-4 by T Hl cells acts as a potent antagonist of macrophage function, 
IL-2 receptor sensitivity, IL-2 dependent macrophage proliferation, and production of y-IFN by mononuclear 
cells while enhancing the production of antibody, which is a product of the humoral immune system. Activity 
of the humoral immune system comes at the expense, or down-regulation, of the cellular immune system. 12• 36• 38 
Examining the population using all testing means yielded a test positive rate of 25. 81 % which indicated 
an apparent increase in detection sensitivity. Collins et al. determined a potential 69% sensitivity when SELISA 
and fecal culture were combined compared to approximately 45% sensitivity when each was used 
seperately.4•55•56 Collins et al. suggested that in a rapid eradication program the combination of fecal culture, 
SELISA and y-IFN could increase sensitivity to 97%.67 Due to lack of organism verification we could not 
speculate on the precise increase in sensitivity with the utilization of three testing means. Additionally the lack 
of confidence in the MELISA testing means would diminish any perceived increase in detection. 
Results of this study indicated poor agreement between the three testing methods. As the y-IFN assay 
sampled a completely different immunlogical response the lack of agreement between this assay and the 
determination of antibody would be expected. What was not expected was the lack of agreement between the 
ELISA determinations. Due to the acceptance of the SELISA as a regulatory standard this study does not 
support the use of the MELISA for determination of herd prevalence or detection of individuals to cull. While 
the SELISA is a regulatory standard, the significantly lower age at positive test compared to the y-IFN assay 
should raise concerns that the SELISA in this instance may be operating at a higher sensitivity and lower 
specificity yielding an excess number of false positives. Further supporting evidence of this observation would 
be indicated by the lack of fecal culture positive animals in the sampled individuals. 
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EFFECT OF A SKIN-TEST USING A CELL-FREE SONICATE OF 
MYCOBACTERIUM AVIUM SUBSP. PARATUBERCULOSIS (19698) ON 
THE PRODUCTION OF GAMMA-INTERFERON 
A paper submitted to the American Journal of Veterinary Research 
M.A. Kirkpatrick1, K. W. Kersting1, J. R. Stabei2, B. V. Thomsen3 and D. J. Nordman4 
Introduction 
Mycobacterium avium subsp. paratuberculosis is the causative agent of a chronic enteritis called 
paratuberculosis (Johne's disease) . Infection produces a granulomatous inflammation that affects the caudal 
region of the small intestine, the ileocecal valve, the cecum, and associated lymph nodes.3 Johne's disease is 
manifested by rapid weight loss, diarrhea, and failure to respond to therapy. Infection with M. paratuberculosis 
causes a leakage of plasma proteins to occur across the intestinal wall, along with malabsorption of dietary 
amino acids from the intestinal contents. 11 Affected animals may manifest a "bottle jaw" appearance 
(mandibular edema) due to the loss of vascular proteins. 16 
Paratuberculosis affects all ruminants including cattle, sheep, goats, deer, antelope, and bison. 1'3'4 Cattle 
become infected as calves through oral ingestion of the bacilli through fecal, colostral or milk contamination, or 
through in-utero infection.4 Due to the pathogen's slow growth patterns, clinical disease doesn't become 
evident until two to five years of age.4 This economically devastating disease is estimated to cost $222 million 
in annual losses in the US alone. 7• 8 
A new development in Johne's testing procedures is the evaluation of cell-mediated immunity through 
measurement of gamma-interferon (y-IFN) produced by stimulated T-cells. The first measurable immunological 
response of an infected individual is mediated by activated T-lymphocytes. 12 This is reflected by delayed type 
hypersensitivity (DTH) reactions and the release of cytokines such as_y-IFN. 12 Anti-mycobacterial action is 
accomplished through macrophage activation mediated by CD4+ TH 1 cells and its secreted cytokines, y-IFN and 
IL-2. Gamma-interferon is produced by CD4+, CDS\ and gamma/delta (y/8) receptor T-cells and natural killer 
cells. Activation of the macrophage population through cytokine induction is responsible for the initiation of 
tumor cell lysis, release of reactive oxygen and nitrogen intermediates, expression of major histocompatibility 
complex class II antigens, and secretion of arachadonic acid metabolites. There is a direct relationship between 
y-IFN presence and activation of macrophages and their ability to kill intracellular pathogens. 12 
The y-IFN assay promises improvement in Johne's disease diagnosis. A study by Wood et al. (1991) 
tested six herds infected with Johne's disease.63 Testing methods included the y-IFN and absorbed ELISA 
1Iowa State University, Veterinary Diagnostic and Production Animal Medicine, Ames, Iowa, and 
2USDA/ARS/National Animal Disease Center, Ames, Iowa 
3 Iowa State University, Veterinary Pathology Department 
4 Iowa State University, Statistical Department 
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assays. Verification oftest results was performed on diseased cattle removed from the herd through the use of 
fecal culture and histopathological examination of the tissues collected at post mortem. Gamma-interferon was 
equally sensitive in detecting subclinical (71.8% to 93 .3%) and clinical animals (100%) whereas the absorbed 
ELISA was more sensitive in detecting cattle with advanced infections (80%) than those with subclinical 
infections (20.5% to 26.6%).63• 65 Work by Bilman-Jacobe et al. suggested that the specificity was 97.6% for 
the y-IFN enzyme-linked immunosorbent assay (EIA).65 
Bovine tuberculosis eradication programs have a longer history and have been in place in the US since 
191 7 when overall animal-level prevalence was 5%. 13 The caudal fold skin test has been the primary means of 
detection and is conducted using an intradermal injection of a M bovis purified protein derivative (PPD). In 72 
hr the injection site is examined for the presence of a palpable nodule. Some countries have adopted the y-IFN 
assay as a supplementary procedure. For example, cattle in New Zealand are initially tested using the 
intradermal skin test with reactors being subsequently examined with the y-IFN assay. Because of this testing 
sequence a natural research question is what effect does an intradermal PPD injection have on the production of 
y-IFN in a skin test positive animal. 
Whipple et al. demonstrated increased production (p < 0.01) of y-IFN by stimulated cells after 
administration of a M bovis PPD intradermal injection used in a caudal fold skin test. 13 Optical density (OD) 
values of the y-IFN EIA for samples taken 72-hr post-sensitization were significantly higher than for samples 
collected prior to skin testing, and higher than samples from cattle that were not skin tested. Rothe! et al. 
demonstrated a 2.5-fold increase in y-IFN production following skin testing which peaked at a period of 3 to 5 
weeks post-skin testing. 14 This increase in y-IFN production could potentially enhance the sensitivity of the y-
IFN assay in determining positive reactors to bovine tuberculosis. 
Given the stimulatory responses documented with M bovis, we hypothesized that the same enhanced 
response may be evident during the cell-mediated phase of infection with M. paratuberculosis. This study was 
undertaken to determine if enhancement ofy-IFN levels would occur following skin testing using a cell-free 
sonicate ofM. paratuberculosis strain 19698 (19698 MpS) and to determine if this response was present given 
the more immunologically distant nature of the Johne ' s infection site in the gut. 12 
Skin testing for Johne 's disease is performed using a PPD of M. paratuberculosis. This product is 
derived from precipitated proteins secreted by the bacilli into the culture filtrate. 20 19698 MpS is a sonication of 
the whole cell containing internal and external, as well as secreted proteins of M. paratuberculosis. The 
investigators chose to use 19698 MpS as the inclusion of cellular proteins could prove more immunogenic in 
both skin testing and stimulation of the y-IFN assay cell cultures than the standard M paratuberculosis PPD. 
Additionally, whole cell cultures of M. paratuberculosis strain 19698 for sonication are relatively easier to 
produce than a PPD. 
Materials and Methods 
Classification trial. The cattle used in the study were obtained from the Ames Dairy facility at Iowa 
State University. This teaching herd representing the six major dairy breeds consists of 102 Holsteins, 26 
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Jerseys, 8 Guernseys, 17 Ayrshires, 17 Brown Swiss, and 9 Milking Shorthorns. While no clinical cases of 
Johne's disease have been observed in this herd, initial fecal sampling one year previous indicated a true 
prevalence rate approaching 10 to 12%. 
This study focused on testing procedures that are readily available to the US veterinary practitioner with 
the exception of the y-IFN assay. The herd was sampled in a ten-day period utilizing milk ELISA (MELISA) 
(Dairy Lab Services, Dubuque, IA), serum ELISA (SELISA) (IDEXX Laboratories, Inc., Westbrook, ME), y-
IFN (CSL Limited, Parkville, Victoria, Australia) and fecal culture (National Animal Disease Center, Ames, 
IA). Sampling consisted of obtaining 2 oz of fluid milk for MELISA assay at the regular dairy records 
processing center (DRPC) monthly check. Five days later sampling consisted of obtaining 60 ml of blood that 
was partitioned between a 10-ml sodium heparin tube and three 15-ml serum separator tubes. The heparinized 
whole blood sample was delivered within 6 hours for y-IFN assay. Serum from the separator tubes was used to 
obtain a serum sample for SELISA determination, with the balance being subdivided for serum banking 
purposes. A fecal sample was also submitted for M. paratuberculosis culture. The herd was divided into 3 
groups to facilitate sampling. This sampling process was completed within a 10-day period. 
Milk ELISA, 85 Serum ELISA59 Fecal and Tissue Culture20 and y-lFN assay.20 These assays were 
performed as previously described in the Materials and Methods section of the article, Comparisons of the Milk 
ELISA, Serum ELISA, Gamma-Interferon and Fecal Culture Tests for the Detection of Johne's Disease in an 
Iowa Herd. 79 
19698 MpS Production. Cell-free soluble protein 19698 MpS was prepared by sonication of 1-ml 
volumes of M. paratuberculosis (1 x 109/ml) in phosphate buffered saline (PBS) at 25 W for 25 min. This was 
followed by centrifugation at 1,400 x g for 5 min to pellet the cellular debris. The cell-free supernatant was 
removed and a protein concentrate determined. Final concentration of each PPD or MpS in culture was 10 
µg/ml_20 
Treatment Assignment. Using the results of the initial y-IFN assay and the ELISA determination the 
herd was divided into 4 groups, consisting of cattle with: 
• No response - negative to all testing. 
• y-IFN suspect individuals - optical density (OD) of 0.075 - 0.099 above the negative stimulation (NS) cell 
line. 
• y-IFN positive individuals - OD ~0.10 or greater. 
• Serum ELISA positive individuals - sample/positive (s/p) ratio~ 0.250. 
To be emolled for further testing a cow had to be a member of the first three groups. These three groups 
were considered to be either negative response or early phase M. paratuberculosis reactors. All y-IFN assay 
positive (n = 7) and suspect (n = 8) cattle were emolled in the skin testing portion of the trial. Cattle testing 
negative to both y-IFN assay and serum ELISA were randomized (The SAS System, Software Release 6.12, 
SAS Institute, Cary NC) and (n = 8) were selected for emollment. 
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Emolled cattle were randomly assigned to one of 2 treatments within the negative, suspect and positive 
groups, consisting of an injection of either 100 µg (0.1ml) of 19698 MpS or 0.1 ml of 0.9% saline solution. 
These products were given as an intradermal injection using a tuberculin 1-ml syringe and a 26-gauge, 0.5-inch 
needle. The initial determinations for emollment and balancing of treatments were performed using data 
obtained during the initial sampling period in October 1998. Baseline y-IFN samples were acquired at the start 
of the skin testing project in January 1999 and the final test status (negative, suspect or positive) for statistical 
analysis was determined at the end of the project within the 2 treatment groups. The final assignments yielded 
"n" as follows : MpS-N = 5, MpS-S = 3, MpS-P = 4, Sal-N = 4, Sal-S = 3 and Sal-P = 3. During the project, the 
researchers were blinded to the official status of individual cows. The following are the treatment and status 
designations: 
• MpS-N - Cattle negative to all testing and treated with 100 µg 19698 MpS. 
• MpS-S- Cattle declared suspect at initial y-IFN assay and treated with 100 µg 19698 MpS. 
• MpS-P - Cattle declared positive at initial y-IFN assay and treated with 100 µg 19698 MpS. 
• Sal-N - Cattle negative to all testing and treated with 0.1 ml 0.9% saline. 
• Sal-S - Cattle declared suspect at initial y-IFN assay and treated with 0.1 ml 0.9% saline. 
• Sal-P - Cattle declared positive at initial y-IFN assay and treated with 0.1 ml 0.9% saline. 
On day 0, each cow's head was deviated and secured to the right in a head chute. A blood sample from 
the jugular vein was taken in a 12-ml sodium heparin tube for y-IFN assay determination and delivered for 
processing within 6 hr. This was to determine a pre-skin testing baseline y-IFN level. A mid-cervical area was 
then selected and prepared with a #40 clipper blade to make a single pass 3 in long. The area was prepped 
using a single 3x3 gauze pad soaked in alcohol and the intradermal injection made. 
On subsequent examinations (Day 3, 6 and 9) the skin over the injection site was palpated for the 
presence of a delayed-type hypersensitivity reaction. If present, the diameter of the reaction was measured in 
mm. The investigators elected to measure the diameter of the skin lesion vs. the thickness as it was deemed to 
be a more sensitive measure of activity in the cervical location. To avoid masking of any lesion by skin 
stretching, animals heads were not deviated during acquisition of measurements. Repeat blood samples to 
monitor y-IFN levels were obtained on days 3, 6, 9, 15, and 27 post-injection. 
Exploratory laparotomies. For purposes of test verification an abdominal lymph node and cecal biopsy 
were obtained from all emolled animals. During a 5 day period a flank laparotomy was performed on each 
emolled cow. Starting on day 27 post-injection, 4 to 6 individuals per day were transported 2 miles from the 
Iowa State University Ames Dairy facility to the Veterinary Teaching Hospital at the Iowa State College of 
Veterinary Medicine. On the same day following surgery, the individuals were moved back to their home 
facility, stalls and rations. 
For the surgical procedure each animal was placed in a surgical headgate and chute. The right 
paralumbar fossa and the area over the lumbar vertebra were clipped with a large animal clippers followed by 
clippers using a #40 blade. The surgical site and vertebral area were washed and prepped for surgery using a 3-
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pass technique of disinfectant soaping with a 4x4 gauze pad, followed by wiping using an alcohol soaked 4x4 
gauze pad. A Kakala vertebral block was administered to provide regional anesthesia followed by an additional 
3-pass disinfection routine as described above. An 8 in. incision was then made in the paralumbar fossa. The 
cecum was located and exteriorized to determine the ileaL'cecal junction and the first available lymph node was 
harvested. A site between blood vessels on the cecum was then selected to obtain a 1.0-1 .5 cm diameter biopsy. 
The biopsy site was closed using #2-0 Chromic Gut in a 2-layer inverting closure pattern. The abdominal 
muscular layers were closed in a 3-layer closure pattern using #3 Vicryl. The final skin closure was made using 
#3 Vetafil. All animals recovered uneventfully, and the skin closures were removed 14-21 days post-surgery. 
Tissue samples were submitted for M. paratuberculosis culture at the National Animal Disease Center (NADC), 
Ames, Iowa. 
Two of the enrolled cows died prior to surgery due to post calving complications. Cow #1168 became a 
paralysis case due to electrolyte imbalances, and it was decided to euthanize this animal on the last day of the 
study. Cow #1079 was treated for hypocalcemia 6 hr post-calving and died 2 hr after treatment due to peracute 
Clostridial enteritis. Both cows were submitted to the Iowa State University Veterinary Pathology department 
for post-mortem examination and diagnosis. Tissues were harvested, cultured and examined using 
histopathology for the presence of M. paratuberculosis consistent with the established surgical protocol. 
Histopathology. Tissues were fixed in 10% neutral buffered formalin, embedded in paraffin, and 
sectioned at 4 µm. Tissues were then stained with hematoxylin and eosin (H&E), acid fast by the Ziehl Neelsen 
method, and immunohistochemistry with primary antibodies for Mycobacterium bovis for light microscopy. 
Tissues were also stained with auramine O and acridine orange for fluorescent microscopy using an Olympus 
BX-60 microscope with a WIBA filter cube.so The H&E stain was used for general tissue morphology. Acid 
fast staining was employed as the classical mycobacterial stain. Fluorescent staining was used to facilitate 
finding low numbers ofmycobacterium in sections, and the immunostain was utilized as it is more sensitive and 
specific then acid fast staining.s1 
Statistics. The relative difference in the y-lFN determinations from day O was computed for each of the 
following days: 3, 6, 9, 15, and 27. For each day, these relative differences and the actual measurements for y-
IFN values were analyzed with analysis of variance methods (ANOV A - The SAS System, Software Release 
6.12, SAS Institute, Cary NC) to examine the average effect of the various y-lFN/stimulation combinations on 
the y-lFN values and the relative change in y-lFN values from day 0. Both one-way and two-factor 
classification models were fit on each day. Pairwise t-tests between the various y-lFN/stimulation groups were 
performed. Paired t-tests were used to compare the mean responses of 19698 MpS, A vium, and Bovis for the 
y-IFN positive, MpS stimulated cows for each day. Standard error of the means were calculated for each group, 
on each day and are presented in the relevant figures . Relative differences were calculated between days. 
Results 
Sampling periods were modeled after the protocol of a standard Johne ' s delayed type hypersensitivity 
(DTH) skin test, with sampling and measurement periods being conducted at 72 hr (3-day) intervals for the first 
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9 days post-injection (Figure 1). At 72 hr minimal skin reactions were apparent, although a mean reaction 
diameter of 13.8 mm (P < 0.0012) was determined for the MpS-P individuals compared to the day O value. 
Contrary to expectations of diminishing skin reactions, the 144 hr (6-day) sampling period yielded visually 
apparent and distinct cervical area skin lesions (Figure 1). These skin reactions on day 6 displayed mean 
diameters of34.9 and 23.5 mm in the MpS-P and MpS-S populations, with a P = 0.0018 and 0.0459 compared 
to day 0, respectively. While not significant, MpS-N individuals on day 6 displayed mean diameters of 17.48 
mm with a P = 0.0545. By 9 days post-skin test the lesion sites had regressed to undetectable levels. When 
comparing skin measurements of day 6 vs. day 3 there were no areas of statistically significant change. 
Cell-mediated immune system activity was indicated by DTH reactions. Similarly to the skin lesion 
activity, y-IFN levels peaked at day 6 (Figure 2). Significant elevations were noted in the MpS-P population on 
day 6 (mean= 0.944), compared to day O (mean= 0.198) with P = 0.0005 . Compared to day 0, y-IFN values 
remained significantly elevated on days 9, 15 and 27 with optical densities and P values of0.467 (P = 0.0325), 
0.455 (P = 0.0293) and 0.619 (P = 0.0004), respectively. The MpS-P values dropped significantly from day 6 to 
day 9, optical density of0.944 to 0.467 (P = 0.0001), while no significant change was evident between day 9 
and 15. On day 27 following the skin test there was a significant elevation in the y-IFN optical density. The 
values increased from 0.455 to 0.619 with P = 0.0362. 
The y-IFN levels were also examined utilizing daily mean differences (Figure 3). Values were obtained 
by using days 3 through 27 samples and subtracting day O baseline values from each. The same trends existed 
in this study as in the daily value analysis, with the exception that the 19698 MpS stimulated elevations became 
visually more evident as the "steady-state" saline reactions were removed from consideration through the 
subtraction of day O baselines. Statistical significance was the same as documented in the daily y-IFN analysis. 
On day 3 Sal-S was considered significantly lower (P = 0.0131) than MpS-P, Sal-P, and MpS-S. The drop in y-
IFN optical density on day 9 vs day 6 was more visually apparent after removal of the "baseline" day O values, 
as was the elevation on day 27. 
Cattle injected with saline exhibited no increase in y-IFN levels at the 3 or 6-day interval, nor was there a 
significant increase in skin lesion diameters in these individuals. The exception was the Sal-P group, which 
exhibited skin lesions diameters of 2.6 mm and 9.5 mm on days 3 and 6 respectively. These were not 
considered to be significant elevations in DTH response. This same group also, exhibited higher overall levels 
ofy-IFN during the pre-injection and post-injection phases than the Johne's positive animals skin tested with 
MpS. While the overall y-IFN response was elevated it remained flat at the MpS 144 hr peak. The high overall 
Sal-P reaction was due primarily to the high readings exhibited by one individual (#1278), thus increasing the 
overall level of the group. 
In addition to stimulation using 19698 MpS, the cell samples of the y-IFN assay were stimulated using 
M. avium PPD (AvPPD) and M. bovis PPD (BoPPD) (Figure 4). The administration of the skin test using 
19698 MpS stimulated a 4.76-fold increase in y-IFN produced by the MpS-P individuals on day 6 compared to a 
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Figure 1. Skin Lesion Diameter (mm) post skin test on day 0. Error bars are standard error of the mean. 
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Figure 2. Daily Gamma-Interferon determinations in units of optical density. Error bars are standard error of 
the mean. Values above the error bars represent significant P-values. 
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Figure 3. Daily Gamma-Interferon determinations minus Day O values in units of optical density. Error bars 
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Figure 4. Gamma-Interferon daily determinations from MpS-P cattle (n = 4) measuring Gamma-Interferon 
produced by 19698 MpS, Avium PPD and Bovis PPD as culture stimulagens. Expressed in Optical 
Density units. Numbers were too low for meaningful statistical analysis. 
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elevations diminished by day 9 to levels that were 2.36, 1.17 and 0.995-fold increases over day-0 measurements 
for 19698 MpS, AvPPD and BoPPD, respectively. At day 15 AvPPD levels exceeded the y-IFN levels for the 
19698 MpS. This trend continued through day 27 . Statistical significance for comparison between the 
stimulants was difficult to ascertain due to the small number of individuals occupying the MpS-P category 
(n = 4). 
Tissue samples were obtained for verification of Johne ' s disease status via flank laparotornies and post-
mortem sampling. Following culture and staining procedures no granulomatous lesions consistent with M 
paratuberculosis were seen in any of the sections, nor were any bacteria consistent with M paratuberculosis 
observed. All culture attempts on harvested samples were negative. 
Discussion 
Results of this study indicate that pre-inoculation of animals with 19698 MpS significantly increased 
production ofy-IFN in cattle declared to have positive (MpS-P) baseline y-IFN responses for Johne's disease. 
Peak production ofy-IFN occurred at 144 hr (day 6) following skin testing. This elevation was statistically 
significant at the P level of0.0005 for MpS-P (Figure 2). Examination of the daily means minus day 0 baseline 
values verified the significance and lent further visual evidence to the significance of the elevation of MpS-P (P 
= 0.0005). 
Work by Whipple et al. 13 and Rothe! et al. 14 focusing on use of the y-IFN assay in detection of M bovis 
infection demonstrated enhanced production ofy-IFN following an intradermal injection of M bovis PPD. 
Rothel demonstrated peak levels at 28 days post-injection, while Whipple 's study showed peak stimulatory 
effect at 4 days. These increases persisted and did not return to pre-injection levels at 28 (Whipple) or 59 days 
(Rothel) post-skin testing in either study. With the introduction ofy-IFN testing for M paratuberculosis it 
could be postulated that a similar stimulatory response would occur. As demonstrated in Whipple and Rothel's 
M bovis work, this study showed a significant elevation (P = 0.0005) ofy-IFN in individuals declared y-IFN 
positive (MpS-P) and stimulated with 19698 MpS. Peak concentrations occurred at 6 days post-injection. 
Unlike Whipple and Rothel ' s M bovis studies, y-IFN levels dropped significantly by day 9 compared to day 6 
(P = 0.0001) to a level that still remained significantly above the pre-injection baseline ( day 0) for the duration 
of the study (P = 0.0325). At day 27 though, y-IFN again increased significantly (P = 0.0039) compared to day 
15. This follows the trend of Whipple and Rothel of elevations that hadn't returned to baseline levels by 28 or 
59 days, respectively. Injection with the 19698 MpS would appear to have more than a transient stimulatory 
effect to the cell-mediated immune system. 
Cattle treated with 19698 MpS and previously designated as y-IFN suspect (MpS-S) and negative (MpS-
N) also demonstrated increases in y-IFN production (Figure 2 and 3). Both elevations were not statistically 
significant. Following peak at day 6, MpS-S and MpS-N cattle returned to previously measured baseline levels 
of y-lFN. As y-IFN elevations were deemed significant only for the MpS-P individuals, it could be suggested 
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that the non-stimulated cut-off level of;?: 0.100 OD above NS for determination of positive status could be valid 
and should be retained. 
As part of the y-lFN testing protocol all blood samples were cross-examined using AvPPD to determine 
if a positive y-lFN reaction was that of M. avium subsp. paratuberculosis or a cross-reaction with M. avium. 
Examination of the Johne ' s y-lFN positive individuals (Figure 4) demonstrated an increase in y-lFN produced 
as a response to stimulation of the cell cultures using 19698 MpS, AvPPD and BoPPD. The dynamics of the 
AvPPD and BoPPD responses were similar to 19698 MpS. While 19698 MpS had the highest response, 
BoPPD had the lowest. All y-lFN levels declined following the peak at 6 days with M. avium overtaking they-
lFN levels stimulated by 19698 MpS at 15 and 27 days. 
An explanation for the documented 19698 MpS and PPD stratification is that the highest response should 
be to the 19698 MpS as this product was used for the skin test procedure. The high response by AvPPD vs. 
19698 MpS is potentially due to high genetic similarity. The genome of M. avium is approximately 98% 
conserved within M. avium subsp paratuberculosis. 20 As M. bovis is less closely related, its y-lFN response is 
less. While cross-stimulation is evident as seen by the responses of the A vPPD and BoPPD, this did not negate 
the ability of the test to determine 19698 MpS positive reactions at day 6. Due to the low population numbers 
of the MpS-P group (n = 4) statistical differences were inapparent. Further evaluation of the cross-stimulation 
effect will have to be examined using higher numbers of positive individuals. Trends indicated in Figure 4 
would suggest that use of skin testing procedures with a y-lFN assay would need to be a timed event to avoid 
confusing cross-reactions with M. avium at 15 and 27 days post-skin test. 
The development of the y-IFN assay has opened an additional door in Johne's disease determinations 
through evaluation of cell-mediated activity. 12•36.63•65 While the response to M. paratuberculosis infection can 
be termed paradoxical, it is generally accepted that the first and most effective response to the presence of this 
organism is through cell-mediated means. 12' 36 The determination ofy-IFN is not in widespread use in the US 
due to test cost, lack of United States Department of Agriculture approval and the requirement that the whole 
blood sample be delivered to the laboratory by 16-hr post-sampling. It does, however, represent a great advance 
by providing a quantitative numerical value indicative of cell-mediated activity. Skin testing procedures have 
the advantage of cost and speed, but suffer from an inherent lack of sensitivity and specificity due to the 
vagaries of individual injection techniques and determinations by testing personnel of a true reaction. 12 
Historically, DTH reactions have been a successful form of testing for the presence of M. bovis. 13• 14 This may 
not be the case when applied to detection of M. paratuberculosis due to the distant location of the gut. 12• 36 
Testing using the y-IFN assay should be considered advantageous over lymphocyte blastogenesis, another cell-
mediated testing means, due to the long incubation time and labor-intensive nature of the latter procedure.12 
Skin testing using 19698 MpS could represent a further enhancement for the y-lFN assay and may have 
merit in two areas. The first advantage is derived from an increase in test sensitivity due to the enhanced nature 
of the y-lFN response. A "magnification" effect was clearly demonstrated when positive individuals manifested 
a 4.76-fold increase over baseline y-lFN levels. However it must be remembered that while not statistically 
64 
significant, all individuals injected with 19698 MpS demonstrated some increase in y-IFN levels. 
Determination of a cutoff "magnification" level would be appropriate so as not to lose specificity with the use 
of this technique. 
A second benefit is related to the current test time limitations of the y-lFN procedure. Since y-lFN 
production is significantly increased using this method, it may be possible to have a valid test with 
transportation times exceeding 16 hr. Further work would be required to validate increased test durability. 
While injection of the 19698 MpS successfully increased the expressed amounts of y-IFN, use of this 
product for skin testing purposes only would not be advisable. Skin reactions were maximal at 144 hr. 
Evaluation of skin lesion data suggests that animals designated as positive and suspect both mounted significant 
skin wheals compared to day 0 (34.93 and 23.54 mm) with P values of0.0018 and 0.0459, respectively. 
Likewise, MpS-N cattle displayed palpable lesions of 17.48 mm with a P value of 0.0545. The lack of 
differences between 19698 MpS injected individuals suggests that clear skin lesion determinations between 
negative and positive may be blurred with the application of this product. 
Rothe! et al. demonstrated an enhanced effect remaining in place at 59 days. 14 Current recommendations 
in the European Union for administration of the DTH skin test for M. bovis suggest this form of testing should 
not be repeated for a minimum of 60 days to allow the animal sufficient time to clear the stimulatory effect. 87 
This may be a potential negative aspect to skin testing as all individuals, whether negative, suspect or positive, 
injected with the sonicate mounted an increased response. Even so, a clear, significant difference emerged 
between animals designated positive vs. those declared suspect or negative. While skin testing with either a 
PPD or sonicate has a lasting effect, y-lFN determinations can be repeated at any time without compromising 
Johne ' s status. Injecting a sonicate or PPD should not be taken lightly and application of this type of 
stimulation should be repeated only on a semi-annual or annual basis. 
Current skin testing protocols require examination of the injection site at 72-hr post-injection to declare a 
positive reaction. Very little response was noted at 72 hr compared to y-IFN levels and skin lesion dimensions 
seen at 144 hr. By the 216 hr (9 day) check, the y-IFN and skin lesions had diminished to baseline levels. The 
delayed response of 144 hr vs. 72 hr is puzzling. This could possibly be explained by the difference in skin 
testing products; traditional PPD vs. 19698 MpS. A PPD is made from precipitating proteins secreted by M. 
paratuberculosis into the culture filtrate, while a sonicate is a whole cell product which contains intracellular 
proteins.20 These two products differ in bacterial protein types and this may account for the delayed 144-hr 
response, as well as the increased diameter skin lesions seen in cattle injected with 19698 MpS. Given the 
observed delayed response in DTH activity, this observation may call into question evaluating DTH responses 
at only the 72-hr sampling period. A second period of examination at 144 hr post-injection may be 
advantageous. 
As a verification step, biopsy samples were obtained for tissue culture purposes. No positive animals 
were found among the enrolled individuals. The objective of this study was to examine the early, cell-mediated 
phase of infection by M. paratuberculosis. As culture methods are more accurate during the later phase of 
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infection it may be that no animals were in a stage of disease to allow effective culturing. Furthermore, culture 
and the y-lFN assay are determining two entirely different populations as y-lFN examines early cell-mediated 
immune system activity, while culture detects later phase shedding. While culturing has a very high specificity 
(99 .9%) it must be kept in mind that the sensitivity of this test is 45% to 50% due to intermittent shedding 
which limits test positive yield.4 
Previous work has indicated that the serum ELISA prescreening examination may have had an 
inordinately high number of false positives in this herd. 79 The test positive rate was 7.4 1 % with the age at 
positive test of37.21 months. Examination of the herd using y-IFN indicated a test positive rate of 4.40% and 
an age at positive test of 48.25 months. The age of serum ELISA positive cattle was significantly lower (P = 
0.0192) than the y-IFN and milk ELISA testing means. These results contrast with the current knowledge of the 
progression of immune system responses to M. paratuberculosis infection. It is generally accepted that the first 
and most effective response to the presence of this organism is through cell-mediated means. 12' 36 Given the low 
number ofy-IFN positive tests and finding no culture positive animals in the screening examination, this herd 
may be in the very early stages of Johne ' s disease. A low prevalence rate and being in the early stages of 
disease would tend to complicate the ability to find biopsy culture and histopathology positive animals. 
Whitlock et al. examined the relationship between fecal and multiple tissue cultures at post-mortem.46 
In this study the authors widened their scope from the traditional single tissue samples of ileum, jejunum, 
ileal/cecal valve and associated mesenteric lymph nodes to include multiple samples within the mesenteric 
lymph node chain as well as pulmonary, mandibular, retropharyngeal, hepatic, and supramammary tissue 
samples. Their conclusions indicated that some of the 55 cattle with negative fecal and tissue cultures had 
infected tissues that were not detected with the limited tissue samples obtained. The proportion of these 
infected, previously undetected, animals is difficult to estimate but could be as high as 20%. Additional 
samples were not obtained in this study because this would have required the sacrifice of the enrolled animals. 
The subjects were active production individuals and sacrifice was not possible. An alternative would be 
conducting long-term herd monitoring using annual serum ELISA and fecal cultures along with post-mortems 
following animal removal to determine the accuracy of various forms of testing procedures. 
Results of this study indicate that skin testing of y-IFN positive individuals using a M. paratuberculosis 
cell-free sonicate yielded significantly increased amounts ofy-lFN produced from sensitized lymphocytes. 
Further research is warranted to determine if the addition of skin testing to the y-IFN testing method could 
increase test sensitivity or durability. 
66 
GENERAL CONCLUSIONS 
The history of Johne ' s disease is filled with the frustration of dealing with a disease syndrome that 
defines the term insidious. The long-term growth pattern of Mycobacterium paratuberculosis defies research 
efforts to deal with it in an expedient manner. These same growth patterns lull producers into a false sense of 
security when they believe they are dealing with Johne's by culling clinical cases. Research has also been 
hampered by the paradoxical immune system response of the disease. 12 Thus, the ability to define a subject 
bovine as truly negative for testing purposes becomes a "best guess" effort. 
Research is beginning to make some imoads into Johne ' s disease through development of tests with 
increasing amounts of sensitivity while maintaining high levels of specificity. This is occurring in all fields of 
testing including culture, PCR identification, antibody detection, and y-lFN determinations. With increasing 
sensitivity and specificity the question will shift from the inadequacies of the testing procedures to how 
committed the producer is to removing identified M. paratuberculosis infected animals from the premises. This 
may become an even more pressing issue if a definitive link with human Crohn's disease is established. 
Comparisons of Testing Procedures for the Detection of Johne's Disease 
In performing the experimentation that produced the Chapter 3 journal article, the authors experienced 
the frustration of determining the true status of individual cows. Evaluation of the data for mean values at 
positive test indicated that the serum enzyme-linked immunosorbant assay (SELISA) had a significantly lower 
age (37.2 vs. 50.5 and 48.3 months respectively) at positive test (P > JTI = 0.0192) than did the milk enzyme-
linked immunosorbant assay (MELISA) or gamma-interferon assay (y-IFN). This raises potentially serious 
questions. Patterns of measurable response will vary from animal to animal, but active proliferation and 
differentiation of T cells is generally the first measurable immune system response through DTH reactions or 
assay ofy-lFN. 12 It would be expected that the y-lFN assay would have the lowest mean positive age vs. the 
antibody determinations. Furthermore, as the majority of lgG in milk originates from serum there should be 
little difference between the mean ages of the MELISA and SELISA methods.61 Additionally, no fecal culture 
positive animals were found in this herd. This would raise serious concerns that the SELISA and MELISA 
methods are overly sensitive in determining a positive designation. Due to these concerns, the results of the 
regulatory standard SELISA test in this herd could be questioned for the presence of false positives due to the 
significantly lower mean age at positive test. 
The MELISA test has recently been offered in Iowa by Iowa Dairy Lab Services Inc., for use in 
determining potential herd prevalence rates and individual determinations of Johne's disease.85 This method 
offers convenient sample collection compared to serum and can be obtained through routine milking 
procedures, thus limiting stress to cattle.61 This study indicates the MELISA determined the highest percentage 
of test positive animals at 12.96%. While this high rate of sensitivity looks encouraging, comparison with the 
results of the regulatory standard SELISA test casts some doubt. When compared using an XYplot (Figure 1, 
Chapter 3) no common individuals were identified as test positive by both tests. Analysis of the proportions in 
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each quadrant with the kappa statistic at -0.116 indicated a very low percentage of agreement between the two 
testing means. The amount of agreement present could simply be due to chance. Sweeney et al. used a 
MELISA containing lipoarabinomannan (LAM) antigen. 62 Their work determined a specificity of 87% ± 8.1 % 
when the sensitivity cutoff was set at 50%. When the cutoff was raised to 60% the specificity dropped to 83% ± 
9.1 %. The predictive value of a positive test using these values for sensitivity and specificity offers only a 29% 
chance that a positive test is correct. This value is too low to be considered useful for culling purposes. 
A recent development in Johne's disease testing has been the introduction of the y-lFN enzyme-linked 
immunoassay (EIA). 12•63•65 This test of the cell-mediated immune system has the advantages of being rapid, 
numerically quantifiable, and not affecting the outcome of further testing through the injection of a PPD. By 
testing an earlier phase response this procedure holds promise of detecting earlier infections of M. 
paratuberculosis, identifying infected individuals prior to or during, early shedding and potentially allowing 
detection in younger cattle. 12•63•65 This study indicated a 4.40% positive rate, with a mean age of detection at 
48.25 months. As this is an earlier phase test, one would expect it to verify the age results seen using the 
SELISA and further identify positive individuals among the younger herd members.12"63'65 The y-IFN assay did 
not verify the results of the SELISA. 
Cross-examinations ofy-IFN results were conducted against the SELISA (Figure 2, Chapter 3) and 
MELISA (Figure 3, Chapter 3). Both antibody tests had similar responses with only 1 individual showing a 
positive agreement between the two types of testing procedures ( antibody vs. interferon). Kappa statistics 
indicated poor agreement between the tests with values of 0.0287 and 0.0005 respectively for the SELISA vs. y-
IFN and MELISA vs. y-lFN. These kappa values would indicate poor agreement between the y-IFN assay and 
antibody determinations. In this case the lack of agreement would be expected. As seen in the kappa values, 61 
the difference between the two testing means indicates that two entirely different populations are being selected. 
Identification of separate populations would "widen the area of capture" and could result in increased sensitivity 
when used in a parallel manner. The MELISA and SELISA assays don't detect differing populations and as a 
result no increase in sensitivity should be expected with parallel testing using these two diagnostic modalities. 
Examining the population using all testing means yielded a test positive rate of 25. 81 % which indicated 
an apparent increase in detection sensitivity. Collins et al. determined a potential 69% sensitivity when SELISA 
and fecal culture were combined compared to approximately 45% sensitivity when each was used 
seperately4'55'56• Collins et al. suggested that in a rapid eradication program the combination of fecal culture, 
SELISA and y-IFN could increase sensitivity to 97%.67 Due to lack of organism verification we could not 
speculate on the precise increase in sensitivity with the utilization of three testing means. Additionally the lack 
of confidence in the MELISA testing means would diminish any perceived increase in detection. 
Results of this study indicated poor agreement between the three testing methods. As the y-IFN assay 
sampled a completely different immunlogical response the lack of agreement between this assay and the 
determination of antibody would be expected. What was not expected was the lack of agreement between the 
ELISA determinations. Due to the acceptance of the SELISA as a regulatory standard this study does not 
68 
support the use of the MELISA for determination of herd prevalence or detection of individuals to cull. While 
the SELISA is a regulatory standard, the significantly lower age at positive test compared to the y-IFN assay 
should raise concerns that the SELISA in this instance may be operating at a higher sensitivity and lower 
specificity yielding an excess number of false positives. Further supporting evidence of this observation would 
be indicated by the lack of fecal culture positive animals in the sampled individuals. 
Effect of a Skin-test on the Production of Gamma-Interferon 
Results of this study indicate that pre-inoculation of animals with 19698 MpS significantly increased (P 
= 0.0005) production ofy-lFN in cattle declared to have positive (MpS-P) baseline y-IFN responses for Johne 's 
disease. Peak production ofy-IFN occurred at 144 hr (day 6) following skin testing (Figure 2 Chapter 4). 
Examination of the daily means minus day O baseline values lent further visual evidence to the significance of 
the elevation ofMpS-P (P=0.0005) through the enhancement of positive increases by the removal of day 0 
baseline levels (Figure 3 Chapter 4). 
Cattle treated with 19698 MpS and previously designated as y-IFN suspect (MpS-S) and negative (MpS-
N) also demonstrated increases in y-lFN production (Figure 2 and 3). Both elevations were not statistically 
significant. Following peak at day 6, MpS-S and MpS-N cattle returned to previously measured baseline levels 
ofy-lFN. As y-IFN elevations were deemed significant only for the MpS-P individuals, it could be suggested 
that the cut-off level of~ 0.100 OD over the negative stimulation culture for determination of positive status 
could be valid and should be retained. 
The development of the y-lFN assay has opened an additional door in Johne ' s disease determinations 
through evaluation of cell-mediated activity. While the response to M. paratuberculosis infection can be 
termed paradoxical, it is generally accepted that the first and most effective response to the presence of this 
organism is through cell-mediated means 12•36.63•65• The determination ofy-IFN is not in widespread use in the 
US due to test cost, lack of United States Department of Agriculture approval and the requirement that the 
whole blood sample be delivered to the laboratory by 16-hr post-sampling. It does however, represent a great 
advance by providing a refereed numerical value indicative of cell-mediated activity. Skin testing procedures 
have an advantage of cost and speed, but suffer from an inherent lack of sensitivity and specificity due to the 
vagaries of individual injection techniques and determinations by testing personnel of a true reaction. 12 
Historically, DTH reactions have been a successful form of testing for the presence of M. bovis. 13' 14 This may 
not be the case when applied to detection of M. paratuberculosis due to the distant location of the gut. 12• 36 
Skin testing using 19698 MpS could represent a further enhancement for the y-IFN assay and may have 
merit in two areas. The first advantage could come from an increase in test sensitivity due to the enhanced 
nature of the y-lFN response. A "magnification" effect was clearly demonstrated when positive individuals 
manifested a 4.76-fold increase over baseline y-lFN levels. However it must be remembered that while not 
statistically significant, all individuals injected with 19698 MpS demonstrated some increase in y-IFN levels. 
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Determination of a cutoff "magnification" level would be appropriate so as not to lose specificity with the use 
of this technique. 
A second possible benefit would be related to the current test time limitations of the y-IFN procedure. 
Since y-IFN production is significantly increased using this method, it may be possible to have a valid test with 
transportation times exceeding 16 hr. Further work would be required to validate increased time durability. 
While injection of the 19698 MpS successfully increased the expressed amounts ofy-IFN, use of this 
product for skin testing purposes only, would not be advisable. Skin reactions were maximal at 144 hr. 
Evaluation of skin lesion data suggests that animals designated as positive and suspect both mounted significant 
skin wheals (34.93 and 23.54 mm) with P values of 0.0018 and 0.0459 respectively. Likewise, MpS-N cattle 
displayed palpable lesions of 17.48 mm with a P value of0.0545. The lack of differences between 19698 MpS 
injected individuals suggests that clear skin lesion determinations between negative and positive may be blurred 
with the application of this product. 
Current skin testing protocols require examination of the injection site at 72-hr post-injection to declare a 
positive reaction. Very little response was noted at 72 hr compared to y-IFN levels and skin lesion dimensions 
seen at 144 hr. By the 216 hr (nine day) check, the y-IFN and skin lesions had diminished to baseline levels. 
The delayed response of 144 hr vs. 72 hr is puzzling. This could possibly be explained by the difference in skin 
testing products; traditional PPD vs. 19698 MpS. A PPD is made from precipitating proteins secreted by M. 
paratuberculosis into the culture filtrate, while a sonicate is a whole cell product which contains intracellular 
proteins20. As these two products differ in bacterial protein types this may account for the delayed 144-hr 
response, as well as the increased diameter skin lesions seen in cattle injected with 19698 MpS. Given the 
observed delayed response in DTH activity this observation may call into question evaluating DTH responses at 
only the 72-hr sampling period. A second period of examination at 144 hr post-injection may be advantageous. 
Results of this study indicate that skin testing of y-IFN positive individuals using a M. paratuberculosis 
cell-free sonicate yielded significantly increased amounts ofy-IFN produced from sensitized lymphocytes. 
Further research is warranted to determine if the addition of skin testing to the y-IFN testing method could 
increase test sensitivity or durability 
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